<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="eva70111" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Evol Appl</journal-id><journal-id journal-id-type="iso-abbrev">Evol Appl</journal-id><journal-id journal-id-type="doi">10.1111/(ISSN)1752-4571</journal-id><journal-id journal-id-type="publisher-id">EVA</journal-id><journal-title-group><journal-title>Evolutionary Applications</journal-title></journal-title-group><issn pub-type="epub">1752-4571</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40401264</article-id><article-id pub-id-type="pmc">PMC12093053</article-id><article-id pub-id-type="doi">10.1111/eva.70111</article-id><article-id pub-id-type="publisher-id">EVA70111</article-id><article-id pub-id-type="other">EVA-2024-264-OA.R1</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Vertical Cancer Transmission via Asexual Fragmentation and Associated Cancer Prevalence</article-title></title-group><contrib-group><contrib id="eva70111-cr-0001" contrib-type="author" corresp="yes"><name><surname>Choi</surname><given-names>Jibeom</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7889-1606</contrib-id><xref rid="eva70111-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eva70111-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>snu10@snu.ac.kr</email></address></contrib></contrib-group><aff id="eva70111-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Applied Mathematics</named-content>
<institution>Kyung Hee University</institution>
<city>Yongin</city>
<country country="KR">Republic of Korea</country>
</aff><aff id="eva70111-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">School of Computational Sciences</named-content>
<institution>Korea Institute for Advanced Study</institution>
<city>Seoul</city>
<country country="KR">Republic of Korea</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold>
<break/>
Jibeom Choi (<email>snu10@snu.ac.kr</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>5</month><year>2025</year></pub-date><volume>18</volume><issue seq="160">5</issue><issue-id pub-id-type="doi">10.1111/eva.v18.5</issue-id><elocation-id>e70111</elocation-id><history>
<date date-type="rev-recd"><day>03</day><month>3</month><year>2025</year></date>
<date date-type="received"><day>05</day><month>2</month><year>2024</year></date>
<date date-type="accepted"><day>28</day><month>4</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Evolutionary Applications</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:EVA-18-e70111.pdf"/><abstract><title>ABSTRACT</title><p>While sexual reproduction is a general feature of animals, fissiparity and budding are relatively uncommon modes of asexual reproduction by which a fragment from a parent becomes an independent organism. Unlike unitary development, tumor cells can be included in the detached fragment destined to become offspring. Although fragmentation facilitates the vertical transmission of parental tumor cells to nascent progeny, this process requires significantly fewer cell replications than development from a zygote. The former is a risk factor for cancer, while the latter reduces oncogenic mutations during replication, indicating that two opposite effects of carcinogenesis are involved in fragmentation. If fragmentation can significantly reduce the number of cell replications for the development and a small portion of parental cancer is transmitted to the offspring during fragmentation, consecutive fragmentation across generations can gradually diminish the cancer risk of offspring, which I term fragmentational purging. On the other hand, consecutive fragmentation may aggravate the cancer risk of the progeny, a process of fragmentational accumulation. The model results imply that fragmentational purging does not necessarily guarantee the evolution of fragmentation, nor does fragmentational accumulation ensure its exclusion. Other relevant factors including juvenile susceptibility of sexual reproduction and loss of genetic diversity stemming from asexual reproduction can influence the selective advantage of fragmentation. Furthermore, owing to the common features of stemness and self&#x02010;renewal, the existence of pluripotent adult stem cells required for fragmentation could be coupled with elevated cancer risk. The model results across diverse parameters and the associated mathematical analyses highlight multifaceted evolutionary trajectories toward fragmentation. Further investigation of cancer&#x02010;suppression strategies that fragmentational animals employ could provide insights into regenerative medicine and cancer therapy.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="eva70111-kwd-0001">binary fission</kwd><kwd id="eva70111-kwd-0002">budding</kwd><kwd id="eva70111-kwd-0003">cancer</kwd><kwd id="eva70111-kwd-0004">fissiparity</kwd><kwd id="eva70111-kwd-0005">primordial stem cell</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Research Foundation of Korea
</institution><institution-id institution-id-type="doi">10.13039/501100003725</institution-id></institution-wrap></funding-source><award-id>2021R1A6A3A01086754</award-id><award-id>RS&#x02010;2024&#x02010;00337511</award-id></award-group></funding-group><counts><fig-count count="6"/><table-count count="2"/><page-count count="16"/><word-count count="10400"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:21.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group id="eva70111-ntgp-0001"><fn fn-type="funding" id="eva70111-note-0001"><p>
<bold>Funding:</bold> J. C. was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. RS&#x02010;2024&#x02010;00337511, No. 2021R1A6A3A01086754).</p></fn></fn-group></notes></front><body id="eva70111-body-0001"><sec id="eva70111-sec-0001"><label>1</label><title>Introduction</title><p>As an outcome of the major transition in the history of life, metazoan multicellularity is characterized by the dependency of constituent cells on the organism and the division of labor (differentiation). For instance, a human pancreatic beta cell (unless it is cancerous) is specialized for the secretion of insulin and cannot persist when detached from the body. The conventional understanding of metazoan obligate multicellularity is that germ cell lineages monopolize the capability to transmit their genetic materials to the subsequent generations, referred to as the Weissmann barrier (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>). Somatic cells including the cancer cells, on the other hand, eventually perish when the host organism is deceased except for few eccentric cells such as HeLa cells (Masters&#x000a0;<xref rid="eva70111-bib-0032" ref-type="bibr">2002</xref>). However, some types of cancer can be transmitted from organisms to organisms (Ujvari et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0050" ref-type="bibr">2016</xref>). In humans, maternal cancer can be vertically transmitted to infants during pregnancy (transplacental cancer transmission) (Tolar and Neglia&#x000a0;<xref rid="eva70111-bib-0047" ref-type="bibr">2003</xref>). Cancer can be horizontally transmitted via canine coitus or biting between Tasmanian devils (Ujvari et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0050" ref-type="bibr">2016</xref>; Pearse and Swift&#x000a0;<xref rid="eva70111-bib-0036" ref-type="bibr">2006</xref>; Belov&#x000a0;<xref rid="eva70111-bib-0004" ref-type="bibr">2011</xref>). Transmission of tumors via surgical organ transplantation has been reported (Kauffman et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0024" ref-type="bibr">2002</xref>).</p><p>The less attended mode of reproduction is fissiparity, by which an organism is divided into parts and each part becomes an independent organism. As the fragments are composed of multiple cells, the cancer could be included in fragments and transmitted to the subsequent generation. Similarly, cancer cells of the parental organism could be incorporated into the offspring produced by asexual budding. As an evident example, Domazet&#x02010;Lo&#x00161;o et&#x000a0;al.&#x000a0;(<xref rid="eva70111-bib-0011" ref-type="bibr">2014</xref>) experimentally confirmed that transplanted tumors of <italic toggle="yes">Hydra</italic> can be transmitted to the offspring produced by the budding (Figure&#x000a0;<xref rid="eva70111-fig-0001" ref-type="fig">1a</xref>). A higher migration rate of the <italic toggle="yes">Hydra</italic> tumor cells would facilitate the transmission of the tumor cells to the budding polyp. Another experimental result suggests that <italic toggle="yes">Hydra</italic> tumor cells might be vertically and iteratively transmitted across multiple generations (Tissot et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0046" ref-type="bibr">2024</xref>). Analogous processes of vertical tumor transmission in species that reproduce by fissiparity and budding can be envisaged (Figure&#x000a0;<xref rid="eva70111-fig-0001" ref-type="fig">1b,c</xref>). For brevity, let fragmentation refer to fissiparity and budding. In this study, fragmentational purging refers to the reduction of the cancer cells in the mature progeny generated by fragmentation compared to cancer cells of the parental organism. If fragmentation elevates the proportion of cancer cells in the mature progeny, it is labeled as fragmentational accumulation (Definition 1 in Appendix <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><fig position="float" fig-type="FIGURE" id="eva70111-fig-0001"><label>FIGURE 1</label><caption><p>The modes of asexual fragmentation and possible mechanism of vertical cancer transmission. (a) The tumor in <italic toggle="yes">Hydra</italic> can be vertically transmitted to the progeny produced by budding (after Domazet&#x02010;Lo&#x00161;o et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0011" ref-type="bibr">2014</xref>). (b) Tumor cells in planaria performing transverse binary fission would be somatically transmitted to the subsequent generation. (c) Tumor cells in a detached arm of the starfish (fissiparity) will remain in the offspring.</p></caption><graphic xlink:href="EVA-18-e70111-g006" position="anchor" id="jats-graphic-1"/></fig><p>As evidenced by retinoblastoma and other hereditary cancer syndromes, oncogenic mutations in the germ cells can affect the cancer risk of the offspring (Knudson Jr&#x000a0;<xref rid="eva70111-bib-0026" ref-type="bibr">1971</xref>). However, cancer cells themselves cannot be passed on to the offspring by sexual reproduction given that cancerous germ cells cannot form a functional zygote. On the other hand, development from the aggregation of the cells rather than a single zygote can significantly reduce the required cell replication number for maturation&#x02014;the evident risk factor of carcinogenesis (Tomasetti and Vogelstein&#x000a0;<xref rid="eva70111-bib-0048" ref-type="bibr">2015</xref>). Such contrasting effects of fragmentation on cancer susceptibility pose a conundrum of whether fragmentation elevates or suppresses the susceptibility.</p><p>Another feature of the fragmentational (fissiparous or budding) species is the possession of pluripotent primordial stem cells (priSCs) after maturation. Conceptualized by Solana&#x000a0;(<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>), self&#x02010;renewing priSCs have both gametic and somatic potential whose inclusion into the germline generalizes the germline continuity established from the Weismann barrier (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>). It is speculated that priSCs, like germ cells or multipotent stem cells, exhibit a germline multipotency program (GMP) such as <italic toggle="yes">piwi</italic> or <italic toggle="yes">nanos</italic> (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>; Juliano et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0023" ref-type="bibr">2010</xref>). Notable examples of adult primordial stem cells (henceforth, APSCs) are planarian neoblasts and <italic toggle="yes">Hydra</italic> I&#x02010;cells (interstitial stem cells), both of which can produce diverse types of cells. Considering the fragmentational capability of the planarian and <italic toggle="yes">Hydra</italic> combined with the multipotency of priSCs, it is tantalizing to expect that possession of the APSCs could be the prerequisite of fragmentation. GMP&#x02010;expressing APSCs that are comparable to neoblasts and I&#x02010;cells are found in other fragmentational animals including starfish (Fujita et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0015" ref-type="bibr">2023</xref>; Magalh&#x000e3;es et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0031" ref-type="bibr">2023</xref>), annelids (&#x000c1;lvarez&#x02010;Campos et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0002" ref-type="bibr">2024</xref>), sponges (Juliano et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0023" ref-type="bibr">2010</xref>), acoels (Hulett et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0019" ref-type="bibr">2023</xref>), and sea anemones (Miram&#x000f3;n&#x02010;Pu&#x000e9;rtolas et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0034" ref-type="bibr">2024</xref>). There is reliable evidence that there are APSCs in coral (L&#x000f3;pez&#x02010;Nandam et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0029" ref-type="bibr">2023</xref>). Furthermore, APSCs will confer high regenerative capability as revealed in fragmentational animals (Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><p>Despite the evident advantages of the APSCs, the development of the APSCs would be a double&#x02010;edged sword because they share multiple traits with cancer stem cells. Both types of cells can self&#x02010;renew and produce diverse differentiated cells. Due to such commonalities, cancer stem cells may originate from stem cells (Shackleton et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0040" ref-type="bibr">2009</xref>). Consistent with this reasoning, planarian neoblasts and <italic toggle="yes">Hydra</italic> I&#x02010;cells are likely to be implicated in tumorigenesis (Domazet&#x02010;Lo&#x00161;o et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0011" ref-type="bibr">2014</xref>; Voura et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0053" ref-type="bibr">2017</xref>; Van Roten et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0052" ref-type="bibr">2018</xref>; Boutry et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0005" ref-type="bibr">2023</xref>). In other words, APSCs may require a smaller number of driver mutations to become cancerous as they are already equipped with stemness and self&#x02010;renewal capability. Furthermore, GMP may play a critical role in cancer stem cells (Garcia&#x02010;Borja et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0016" ref-type="bibr">2024</xref>).</p><p>Distinct attributes of fissiparous or budding organisms including APSCs and vertical transmission of cancer cells to the offspring must be pivotal factors for cancer susceptibility and the evolution of cancer suppression. Specifically, how would features associated with fragmentation including fragmentation frequency, regeneration capability, or juvenile vulnerability influence the optimal strategy of cancer suppression? To investigate the effect of asexual fragmentation on cancer evolution, I built a graph&#x02010;theoretical pedigree framework illustrating different modes of sexual and asexual reproduction. During the lifetime of an organism in the proposed model, different types of cells accumulate mutation and proliferate, influenced by the level of cancer&#x02010;suppression capability.</p><p>The theoretical formulation based on evolutionary principles and examination of cancer susceptibility across diverse model parameters demonstrates the conditions that favor asexual fragmentation and how they affect cancer prevalence. This may explain the production of efficient tumor&#x02010;suppressing substances in numerous fragmentational marine organisms that have possible medical applications (Macedo et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0030" ref-type="bibr">2021</xref>). Furthermore, this study provides evolutionary insight into why comprehensive regeneration is inhibited in animals composed of highly differentiated cells. To my knowledge, no study to date has mathematically investigated the effect of vertical cancer transmission by fragmentation on cancer prevalence across multiple generations.</p><p>In this model, the cancer of multicellular animals (Metazoa) was taken into account. The plants were not considered because plant tumors are generally less lethal and caused by infections rather than spontaneous mutations (Doonan and Sablowski&#x000a0;<xref rid="eva70111-bib-0012" ref-type="bibr">2010</xref>).</p></sec><sec id="eva70111-sec-0002"><label>2</label><title>Model Formulations</title><sec id="eva70111-sec-0003"><label>2.1</label><title>Cell Types and Organism Composition</title><p>Based on the degree of oncogenic mutations in a cell, three levels of cell states were postulated in this model&#x02014;normal cells, defective cells, and cancerous cells. Defective cells possess certain oncogenic mutations though they are yet to be cancerous. Mutations in normal cells turn them into defective cells. Additional mutations make defective cells cancerous. As revealed in Figure&#x000a0;<xref rid="eva70111-fig-0002" ref-type="fig">2a</xref>, normal cells are illustrated with bright spherical morphology, while defective cells are in darker colors. Cancer cells exhibit rumpled surfaces.</p><fig position="float" fig-type="FIGURE" id="eva70111-fig-0002"><label>FIGURE 2</label><caption><p>Growth and mutation diagram of unitary development (sexual reproduction) used in this study. (a) The brightness of a cell illustrates whether the cell is normal. Darker colors imply the existence of oncogenic mutations. Round&#x02010;shaped and bright cells are normal; round&#x02010;shaped and dark cells are defective; rumpled and dark cells are cancerous. Once embryogenesis is finished, the blue hue indicates somatic cells excluding APSCs. The red hue is allocated to germ cells (sperms and eggs). For an organism containing APSCs, yellow cells illustrate APSCs. When such cells are absent, yellow cells illustrate PGCs. Weismann barrier in this study follows the generalized framework proposed by Solana&#x000a0;(<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>). Under this perspective, APSCs are included in the germline as mutations in them can be directly transmitted to the progeny. (b) Under the preformation and rudimentary priSC model (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>), gametic and somatic fates are determined during embryogenesis. A normal zygote establishes a blastula composed of normal cells. The zygote is illustrated with a yellow hue considering their totipotency. Similarly, yellow cells in the blastula have gametic potential. After embryogenesis, PGCs (yellow cells) can produce germ cells, while mutations in somatic cells (blue cells) cannot be transmitted to the offspring. As replication proceeds, normal PGCs and somatic cells become defective, and defective cells become cancerous (black downward arrows). Normal, defective, cancerous PGCs are assumed to produce normal, defective, cancerous germ cells, respectively (red leftward arrows). (c) In this study, the possession of the multipotent APSCs is the prerequisite for the fragmentation. APSCs have both gametic and somatic potential. The composition of somatic cells under this model is partially influenced by APSC composition with the coefficient <mml:math id="jats-math-1" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math> (Equation&#x000a0;(<xref rid="eva70111-disp-0010" ref-type="disp-formula">10</xref>)). (d) Same as (b) when the zygote is a defective cell. This organism does not have any normal cells. (e) Same as (c) when the zygote is a defective cell. (f) The explanation of the arrows used in (b)&#x02013;(e). APSC, adult primordial stem cell; GMP, germline multipotency program; PGC, primordial germ cell; priSC, primordial stem cell.</p></caption><graphic xlink:href="EVA-18-e70111-g004" position="anchor" id="jats-graphic-3"/></fig><p>Once embryonic development is finished, three categories of adult cells depending on their functions were postulated. Somatic cells including adult stem cells (except APSCs) or progenitor cells (except primordial germ cells) are illustrated with a blue hue. In other words, it is defined in this model that adult somatic cells cannot directly transmit their genetic material to the progeny via sexual reproduction (evolutionary bystanders). Normal cells that exhibit the GMP excluding the germ cells are described with a yellow hue. Under preformation model (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>), yellow cells after embryogenesis represent primordial germ cells (PGCs). On the other hand, yellow cells after embryogenesis represent PGCs and APSCs under unlimited priSC model (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>) such as neoblasts or I&#x02010;cells.</p><p>If developed from a normal zygote, all cells immediately after embryogenesis were assumed to be normal (Figure&#x000a0;<xref rid="eva70111-fig-0002" ref-type="fig">2b,c</xref>). As replication proceeds, defective and cancerous cells arise. If developed from a defective zygote, all cells immediately after the embryogenesis were assumed to be defective (Figure&#x000a0;<xref rid="eva70111-fig-0002" ref-type="fig">2d,e</xref>).</p><p>Let <mml:math id="jats-math-2" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-3" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-4" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> denote the proportions of the normal, defective, and cancerous PGCs/APSCs in an organism at <mml:math id="jats-math-5" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math>, respectively (Figure&#x000a0;<xref rid="eva70111-fig-0002" ref-type="fig">2b</xref>). Here, <mml:math id="jats-math-6" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math> is the number of cell replications, postulating that <mml:math id="jats-math-7" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math> immediately after embryogenesis or fragmentation. Alternatively, <mml:math id="jats-math-8" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math> may represent the age (the degree of senescence) of an organism given that the replication rate is constant. As these values represent the proportions, <mml:math id="jats-math-9" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>+</mml:mo><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math> regardless of <mml:math id="jats-math-10" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math>. Likewise, <mml:math id="jats-math-11" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-12" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-13" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> represent the proportions of normal, defective, and cancerous somatic cells.</p><p>Based on the two&#x02010;hit hypothesis for tumorigenesis (Knudson Jr&#x000a0;<xref rid="eva70111-bib-0026" ref-type="bibr">1971</xref>), it was postulated that the proportion of the normal PGCs/APSCs monotonically decreases as they transform into defective PGCs/APSCs or cancerous cells grow faster than normal cells. The defective PGCs/APSCs in turn transform into the cancerous PGCs/APSCs. As such, the following differential equations can be formulated.<disp-formula id="eva70111-disp-0001">
<label>(1)</label>
<mml:math id="jats-math-14" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0002">
<label>(2)</label>
<mml:math id="jats-math-15" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0003">
<label>(3)</label>
<mml:math id="jats-math-16" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-17" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> is the transition rate (determined by mutation rate and proliferation of each cell type) from normal to defective PGCs/APSCs, and <mml:math id="jats-math-18" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> is that from defective to cancerous PGCs/APSCs. The general solutions for these differential equations are<disp-formula id="eva70111-disp-0004">
<label>(4)</label>
<mml:math id="jats-math-19" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0005">
<label>(5)</label>
<mml:math id="jats-math-20" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mfrac><mml:mrow><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#x02212;</mml:mo><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0006">
<label>(6)</label>
<mml:math id="jats-math-21" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mfrac><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>t</mml:mi></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>The transition dynamics of the somatic cells have identical structures.<disp-formula id="eva70111-disp-0007">
<label>(7)</label>
<mml:math id="jats-math-22" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">dN</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0008">
<label>(8)</label>
<mml:math id="jats-math-23" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">dD</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0009">
<label>(9)</label>
<mml:math id="jats-math-24" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">dC</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mfrac><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-25" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-26" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> are parameters for somatic mutations that correspond to <mml:math id="jats-math-27" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-28" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>.</p><p>Frequent oncogenic mutations will elevate the transition rates (<mml:math id="jats-math-29" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-30" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-31" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-32" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>). Consequently, the immunity and the functionality of the tumor&#x02010;suppression mechanism should influence the transition rates. The parameter <mml:math id="jats-math-33" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math> in this study represents such a combined cancer&#x02010;suppression capability. Although the oncogenic mutation is absent, the higher growth rate of cancer cells can make transition rates positive as the higher proportion of cancer cells results in a reduced proportion of normal and defective cells.</p><p>For an organism developed from a normal zygote, <mml:math id="jats-math-34" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close="]" open="[" separators=",,"><mml:mrow><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="[" separators=",,"><mml:mrow><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>. If developed from a defective zygote, <mml:math id="jats-math-35" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close="]" open="[" separators=",,"><mml:mrow><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="[" separators=",,"><mml:mrow><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>. The initial proportion of the PGCs/APSCs and somatic cells of an organism developed via fissiparity or budding is determined by the composition of the parental organism (Figure&#x000a0;<xref rid="eva70111-fig-0003" ref-type="fig">3a,b</xref>), which will be explained later.</p><fig position="float" fig-type="FIGURE" id="eva70111-fig-0003"><label>FIGURE 3</label><caption><p>Growth and mutation diagram of fragmentation used in this study. (a) A detached fragment (or bud) from a NU or NF<italic toggle="yes">n</italic> organism is composed of diverse types of cells with different oncogenicity. Following the detachment, the cells in the fragment replicate during which mutation arises. Fragmentation postulates the existence of adult primordial stem cells (APSCs) such as planarian neoblasts and <italic toggle="yes">Hydra</italic> I&#x02010;cells. (b) If the detached fragment originates from a DU or DF<italic toggle="yes">n</italic> organism, no normal cell is included in the fragment. (c) The number of cell replications to reach maturity would be different for unitary development and fragmentation. For unitary development, a single cell needs to replicate to establish a mature organism, hence the required number of the replication would be larger than that of the fragmentation (<mml:math id="jats-math-36" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub><mml:mo>&#x0003e;</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>). In addition, an organism produced via unitary development needs to go through the juvenile period which is vulnerable to predation and starvation. The survival risk and associated fitness reduction of juvenility are reflected in <mml:math id="jats-math-37" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-38" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>. APSC, adult primordial stem cell; priSC, primordial stem cell.</p></caption><graphic xlink:href="EVA-18-e70111-g005" position="anchor" id="jats-graphic-5"/></fig><p>A single zygote needs to repeatedly replicate to reach the cell number of the mature organism. In contrast, a fragment that contains multiple cells needs to replicate fewer times to reach the cell number of maturity. Accordingly, the time or the number of replications to reach maturity would be larger for unitary development compared to those of fragmentation (Figure&#x000a0;<xref rid="eva70111-fig-0003" ref-type="fig">3c</xref>). Let <mml:math id="jats-math-39" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-40" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> denote the number of replications (or equivalent to the time given that the replication rate is constant) required to reach maturity by unitary development and fragmentation, respectively. It was assumed in the model that <mml:math id="jats-math-41" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub><mml:mo>&#x0003e;</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>. Refer to the Section&#x000a0;<xref rid="eva70111-sec-0006" ref-type="sec">3</xref> for the simplified mathematical analysis.</p><p>As all metazoans can reproduce by unitary development (sexual reproduction or parthenogenesis) (Queller&#x000a0;<xref rid="eva70111-bib-0037" ref-type="bibr">2000</xref>; Grosberg and Strathmann&#x000a0;<xref rid="eva70111-bib-0017" ref-type="bibr">1998</xref>), the same argument was set in this model. Considering that parthenogenesis without sexual reproduction is not a common mode of reproduction in nature (Vakhrusheva et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0051" ref-type="bibr">2020</xref>), unitary development solely refers to the outcome of sexual reproduction in this study. A new organism can be established from a normal or defective zygote (Figure&#x000a0;<xref rid="eva70111-fig-0004" ref-type="fig">4a</xref>). Let type NU denote the organisms originating from a normal zygote. Type DU refers to the organism developed from a defective zygote. All cells of DU organisms are either defective or cancerous.</p><fig position="float" fig-type="FIGURE" id="eva70111-fig-0004"><label>FIGURE 4</label><caption><p>The modes of reproduction and population dynamics used in this study. (a) An NU organism can produce a normal zygote which will later become an NU offspring. An NU organism can also produce a defective zygote, becoming a DU offspring. If a progeny is established from a fragment detached from the NU parent, the progeny becomes an NF1 organism. (b) NF1 organism can produce NF2 offspring by fragmentation. The NU organism is the fragmentational ancestor of NF1, NF2, and other NF<italic toggle="yes">n</italic> organisms. Likewise, the DU organism is the fragmentational ancestor of DF<italic toggle="yes">n</italic> organisms where <italic toggle="yes">n</italic> refers to the number of consecutive fragmentations across generations. (c) The pedigree of the model. At the first generation (Gen. 1), all population was assumed to be composed of NU organisms. Owing to spatial limitations, N and D refer to NU and DU organisms, respectively. NU organisms can produce NU, DU, and NF1 organisms in the subsequent generation (Gen. 2). NF<italic toggle="yes">i</italic> and DF<italic toggle="yes">i</italic> organisms can produce NF(<italic toggle="yes">i</italic>&#x02009;+&#x02009;1) and DF(<italic toggle="yes">i</italic>&#x02009;+&#x02009;1) organisms, respectively, by fragmentation. In addition, NF<italic toggle="yes">i</italic> organisms, by sexual reproduction, can produce NU and DU organisms, while DF<italic toggle="yes">i</italic> organisms can only produce DU organisms by sexual reproduction. Based on the subpopulation size and fitness of each type, the population composition of the subsequent generation can be estimated. Red and black arrows indicate the unitary development via normal and defective zygotes, respectively. The blue arrow corresponds to the fragmentation.</p></caption><graphic xlink:href="EVA-18-e70111-g001" position="anchor" id="jats-graphic-7"/></fig><p>Let <mml:math id="jats-math-42" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-43" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math> and, <mml:math id="jats-math-44" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math> denote the proportion of normal, defective, and cancerous PGCs/APSCs of NU organisms at maturity, respectively. Note that the superscript <mml:math id="jats-math-45" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>V</mml:mi></mml:mrow></mml:mrow></mml:math> is not the numeric value representing the power. Rather, it is a categorical label representing the NU type. Specifically, <mml:math id="jats-math-46" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-47" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math> with <mml:math id="jats-math-48" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math> (Equations&#x000a0;<xref rid="eva70111-disp-0004" ref-type="disp-formula">(4)</xref>, <xref rid="eva70111-disp-0005" ref-type="disp-formula">(5)</xref>, <xref rid="eva70111-disp-0006" ref-type="disp-formula">(6)</xref>). In addition, <mml:math id="jats-math-49" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>&#x02212;</mml:mo><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>. For DU organisms, <mml:math id="jats-math-50" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>W</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-51" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>W</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math> with <mml:math id="jats-math-52" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>. Similarly, let <mml:math id="jats-math-53" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-54" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math> denote the proportion of normal and defective somatic cells of NU organisms at maturity. Under the preformation model lacking APSCs, <mml:math id="jats-math-55" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-56" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>=</mml:mo><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mrow></mml:math> with <mml:math id="jats-math-57" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mn>0</mml:mn></mml:mfenced><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>.</p><p>Let <mml:math id="jats-math-58" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math> denote the proliferability of APSCs (<mml:math id="jats-math-59" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x02264;</mml:mo><mml:mi>&#x003b8;</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>), which influences the production of somatic cells, oncogenicity, and regenerative capability. If APSCs that can generate the somatic cells are present, the composition of the somatic cells at maturity is influenced by the parameter <mml:math id="jats-math-60" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math> (Figure&#x000a0;<xref rid="eva70111-fig-0002" ref-type="fig">2c,e</xref>).<disp-formula id="eva70111-disp-0010">
<label>(10)</label>
<mml:math id="jats-math-61" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msup><mml:mi>N</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msup><mml:mi>D</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msup><mml:mi>N</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msup><mml:mi>D</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>&#x003b8;</mml:mi><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>which indicates that the composition of APSCs (<mml:math id="jats-math-62" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-63" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-64" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>) affects the composition of somatic cells at maturity (<mml:math id="jats-math-65" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>N</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-66" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>D</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>). Using such relations, the somatic cell composition of DU organisms under an unlimited priSC model can be similarly described.</p><p>Higher APSC proliferability was assumed to confer higher regenerative capability that alleviates the damage of the physical trauma. As a trade&#x02010;off, higher APSC proliferability is associated with higher transition rates of APSCs (<mml:math id="jats-math-67" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-68" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>) based on the fact that proliferation is linked to tumorigenesis (Jacqueline et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0021" ref-type="bibr">2017</xref>; Ratajczak et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0039" ref-type="bibr">2018</xref>; Cho et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0010" ref-type="bibr">2024</xref>). Consequently, the transition rates are primarily determined by the cancer&#x02010;suppression capability (<mml:math id="jats-math-69" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x0003c;</mml:mo><mml:mi>I</mml:mi><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>) combined with APSC proliferability and biased replication fidelity (<mml:math id="jats-math-70" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:math>).<disp-formula id="eva70111-disp-0011">
<label>(11)</label>
<mml:math id="jats-math-71" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi mathvariant="italic">s&#x003b7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0012">
<label>(12)</label>
<mml:math id="jats-math-72" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">+</mml:mo><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close=")" open="("><mml:mrow><mml:mn>2</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:mfenced><mml:mi>&#x003b7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Here, <mml:math id="jats-math-73" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> is the baseline transition rate determined by the cancer&#x02010;suppression capability <mml:math id="jats-math-74" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math>. As a higher cancer&#x02010;suppression capability reduces mutation rates, <mml:math id="jats-math-75" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> is monotonically decreasing against <mml:math id="jats-math-76" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math>. Refer to Equation&#x000a0;(<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S5</xref>) for its details. While <mml:math id="jats-math-77" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math> is the major contributor to cancer suppression, there could be supplementary APSC&#x02010;specific or somatic&#x02010;cell&#x02010;specific mechanisms of tumor suppression such as differential gene expression or allocation of quiescent subpopulation (Van Roten et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0052" ref-type="bibr">2018</xref>; Cheung and Rando&#x000a0;<xref rid="eva70111-bib-0009" ref-type="bibr">2013</xref>; Mihaylova et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0033" ref-type="bibr">2018</xref>). <mml:math id="jats-math-78" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-79" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mn>2</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>s</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math> represent such disproportionate replication fidelity in PGCs/APSCs and somatic cells. If <mml:math id="jats-math-80" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mrow></mml:math>, for instance, the mutation in somatic cells is suppressed at the cost of elevated mutations in PGCs/APSCs. In this model, five values of <mml:math id="jats-math-81" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:math> were evaluated: 0.5, 0.75, 1, 1.25, 1.5. Furthermore, higher APSC proliferability elevates mutation risk (Jacqueline et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0021" ref-type="bibr">2017</xref>; Ratajczak et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0039" ref-type="bibr">2018</xref>; Cho et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0010" ref-type="bibr">2024</xref>), implemented in the term <mml:math id="jats-math-82" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>+</mml:mo><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math> of Equation&#x000a0;(<xref rid="eva70111-disp-0012" ref-type="disp-formula">12</xref>). For organisms that lack APSCs, <mml:math id="jats-math-83" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math>.</p><p>Stemming from genomic instability or haploinsufficiency, inactivation of an allele of tumor&#x02010;suppression genes can facilitate the subsequent genetic alterations required for carcinogenesis (Smilenov&#x000a0;<xref rid="eva70111-bib-0041" ref-type="bibr">2006</xref>; Konishi et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0027" ref-type="bibr">2011</xref>). As such, transition rates from defective to cancerous cells were assumed to be higher than those from normal to defective cells. Specifically, <mml:math id="jats-math-84" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-85" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>.</p><p>Regardless of the organism types, let <mml:math id="jats-math-86" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-87" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-88" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> denote proportions of the normal, defective, and cancerous somatic cells at maturity, respectively. Likewise, <mml:math id="jats-math-89" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-90" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-91" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> are the proportions of the normal, defective, and cancerous PGCs/APSCs at maturity, respectively. The inherited composition of the progeny produced by fragmentation at birth (<mml:math id="jats-math-92" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>F</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>F</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>) is<disp-formula id="eva70111-disp-0013">
<label>(13)</label>
<mml:math id="jats-math-93" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Composition of somatic cells (<mml:math id="jats-math-94" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-95" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-96" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>) after fragmentation follows the identical relation.<disp-formula id="eva70111-disp-0014">
<label>(14)</label>
<mml:math id="jats-math-97" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mi>N</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>D</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>C</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mfenced close="]" open="["><mml:mtable><mml:mtr><mml:mtd><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mtd></mml:mtr></mml:mtable></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Three nonnegative parameters <mml:math id="jats-math-98" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-99" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-100" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> represent the vertical transmission degree of normal, defective, and cancerous cells. If cancerous cells are highly mobile so that they are readily included in the dividing fragment as in the case of <italic toggle="yes">Pelmatohydra robusta</italic> (Domazet&#x02010;Lo&#x00161;o et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0011" ref-type="bibr">2014</xref>), <mml:math id="jats-math-101" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> would not be significantly smaller than <mml:math id="jats-math-102" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>.</p><p>The fitness of each organism (<mml:math id="jats-math-103" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003c9;</mml:mi></mml:mrow></mml:mrow></mml:math>) is determined by the composition of the somatic cells, cancer&#x02010;suppression capability, and the cost of the damage (physical trauma such as injury or predator attacks).<disp-formula id="eva70111-disp-0015">
<label>(15)</label>
<mml:math id="jats-math-104" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mi>&#x003c9;</mml:mi><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>&#x003c9;</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:msubsup><mml:mi>N</mml:mi><mml:mi>P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:msubsup><mml:mi>D</mml:mi><mml:mi>P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:msubsup><mml:mi>C</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003c7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>&#x003b8;</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>g</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-105" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c9;</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> is the baseline fitness, <mml:math id="jats-math-106" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003c7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>&#x003b8;</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> is the effect of external damage (trauma), and <mml:math id="jats-math-107" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> is the cost of sustaining the cancer&#x02010;suppression capability. <mml:math id="jats-math-108" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>N</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-109" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-110" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> are coefficients that determine how cell composition influences fitness. As a higher proportion of normal cells and a lower proportion of cancer cells will elevate fitness, it was postulated that <mml:math id="jats-math-111" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:mo>&#x02265;</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:mo>&#x02265;</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>. The power <mml:math id="jats-math-112" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> (exponent for <mml:math id="jats-math-113" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>N</mml:mi><mml:mi>P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup><mml:mo>=</mml:mo><mml:msup><mml:mfenced close=")" open="("><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mfenced><mml:mi>&#x003b5;</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>) applied to <mml:math id="jats-math-114" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-115" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-116" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> demonstrates the aggressive and lethality of cancer. As <mml:math id="jats-math-117" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-118" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-119" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> are proportional values such that <mml:math id="jats-math-120" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-121" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x02264;</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub><mml:mo>&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>, the increase in <mml:math id="jats-math-122" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> results in a corresponding decrease in <mml:math id="jats-math-123" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> or <mml:math id="jats-math-124" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>D</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>. As a simple example, compare two cases of somatic composition <mml:math id="jats-math-125" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-126" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>0.9</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>. Here, <mml:math id="jats-math-127" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> depicts an organism purely composed of normal somatic cells. If 10% of the normal cells become cancerous, it is equivalent to <mml:math id="jats-math-128" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>. Let us calculate <mml:math id="jats-math-129" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:msubsup><mml:mi>N</mml:mi><mml:mi>P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>D</mml:mi></mml:msub><mml:msubsup><mml:mi>D</mml:mi><mml:mi>P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:msubsup><mml:mi>C</mml:mi><mml:mi>P</mml:mi><mml:mi>&#x003b5;</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math> for <mml:math id="jats-math-130" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>N</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-131" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>C</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math>. If <mml:math id="jats-math-132" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>, this value is 1 for <mml:math id="jats-math-133" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, and 0.9 for <mml:math id="jats-math-134" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>. If <mml:math id="jats-math-135" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mrow></mml:math>, on the other hand, the value is still 1 for <mml:math id="jats-math-136" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, but it becomes 0.81 (=&#x02009;0.9<sup>2</sup>) for <mml:math id="jats-math-137" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="bold">x</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>. In general, values of <mml:math id="jats-math-138" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> higher than 1 are associated with aggressiveness or fatality of cancer as a slight increase in <mml:math id="jats-math-139" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>P</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> leads to a significant drop in total fitness. In simulation models, I assigned the values of <mml:math id="jats-math-140" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> from 1 to 2 depending on cancer fatality (Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S2</xref>) where higher <mml:math id="jats-math-141" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> implies that cancer is life&#x02010;threatening to that species.</p><p>
<mml:math id="jats-math-142" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003c7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>&#x003b8;</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math> is the fitness reduction due to the external damage that is dependent on the APSC proliferability (<mml:math id="jats-math-143" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math>). Specifically,<disp-formula id="eva70111-disp-0016">
<label>(16)</label>
<mml:math id="jats-math-144" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mi>&#x003c7;</mml:mi><mml:mfenced close=")" open="("><mml:mi>&#x003b8;</mml:mi></mml:mfenced><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi mathvariant="italic">&#x003c4;&#x003b4;</mml:mi><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-145" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003c4;</mml:mi></mml:mrow></mml:mrow></mml:math> is the frequency of the external damage and <mml:math id="jats-math-146" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b4;</mml:mi></mml:mrow></mml:mrow></mml:math> is the severity of the damage in each traumatic event. Higher APSC proliferability reduces the expected damage owing to the high regenerative capability, reflected by <mml:math id="jats-math-147" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math>.</p><p>As in the case of the tumor&#x02010;suppression gene <italic toggle="yes">p53</italic>, higher cancer&#x02010;suppression capability enhances the replication fidelity while overall fitness is accordingly reduced (Jacqueline et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0021" ref-type="bibr">2017</xref>; Tyner et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0049" ref-type="bibr">2002</xref>). Hence, <mml:math id="jats-math-148" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>g</mml:mi><mml:mfenced close=")" open="("><mml:mi>I</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>c</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:msup><mml:mi>I</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mrow></mml:math> for a specific nonnegative coefficient <mml:math id="jats-math-149" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>c</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>.</p></sec><sec id="eva70111-sec-0004"><label>2.2</label><title>Modes of Reproduction and Population Dynamics</title><p>The label NF1 indicates that an organism is reproduced by the fragmentation of an NU organism (Figure&#x000a0;<xref rid="eva70111-fig-0004" ref-type="fig">4b</xref>). If an NF1 organism produces an offspring by fragmentation, the offspring is NF2. In general, the NF<italic toggle="yes">n</italic> organism produces NF(<italic toggle="yes">n</italic>&#x02009;+&#x02009;1) organisms by fragmentation. For NF<italic toggle="yes">n</italic> organisms, the fragmentational ancestor is an NU organism. In other words, fragmentational ancestor is defined as the most ancestral organism in the pedigree that initiated the repeated fragmentation. Here, <italic toggle="yes">n</italic> denotes the number of consecutive fragmentations across generations. DF<italic toggle="yes">n</italic> organisms can be analogously defined whose fragmentational ancestor is a DU organism.</p><p>NF<italic toggle="yes">n</italic> organisms can produce normal or defective zygotes. Hence, the NF<italic toggle="yes">n</italic> organisms can produce NU or DU organisms by sexual reproduction (unitary development). In contrast, it was assumed that DF<italic toggle="yes">n</italic> organisms can only produce defective zygotes as they do not possess normal cells. Thus, all progeny of DF<italic toggle="yes">n</italic> organisms produced by unitary development are DU organisms.</p><p>In each reproductive event of an organism, <mml:math id="jats-math-150" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mrow></mml:math> is the probability that the organism reproduces by fragmentation. Accordingly, <mml:math id="jats-math-151" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mrow></mml:math> is the probability to reproduce sexually. Let <mml:math id="jats-math-152" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-153" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> denote the subpopulation size of the NU and DU organisms at the <italic toggle="yes">j</italic>&#x02010;th generation, respectively. Likewise, <mml:math id="jats-math-154" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-155" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math> are the subpopulation size of NF<italic toggle="yes">i</italic> and DF<italic toggle="yes">i</italic> organisms at the <italic toggle="yes">j</italic>&#x02010;th generation.</p><p>As previously explained, the proportions of the normal, defective, and cancerous PGCs/APSCs of NU organisms at maturity are <mml:math id="jats-math-156" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-157" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-158" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>. It was assumed that cancerous germ cells cannot develop into an organism by unitary development. In each reproduction by unitary development, a normal gamete will be more likely to succeed in reproduction compared to a defective or cancerous gamete. Therefore, the contribution of the NU organisms in the <italic toggle="yes">j</italic>&#x02010;th generation to the subpopulation size of the NU organisms in the (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation is proportional to<disp-formula id="eva70111-disp-0017">
<label>(17)</label>
<mml:math id="jats-math-159" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mfenced><mml:mfrac><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mfrac><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-160" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math> is the fitness (reproductive success) of an NU organism calculated by Equation&#x000a0;(<xref rid="eva70111-disp-0015" ref-type="disp-formula">15</xref>). Again, the superscript <mml:math id="jats-math-161" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>V</mml:mi></mml:mrow></mml:mrow></mml:math> is not a numeric value representing the power: it is the label for NU organisms. <mml:math id="jats-math-162" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-163" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-164" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> reflect the differential success rates in the fertilization of normal, defective, and cancerous germ cells.</p><p>For NF<italic toggle="yes">i</italic> organisms, their contribution to the subpopulation size of NU organisms in the subsequent (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation is proportional to<disp-formula id="eva70111-disp-0018">
<label>(18)</label>
<mml:math id="jats-math-165" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mfenced><mml:mfrac><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mfrac><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where <mml:math id="jats-math-166" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-167" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math>, and <mml:math id="jats-math-168" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math> are the proportions of normal, defective, and cancerous PGCs/APSCs of mature NF<italic toggle="yes">i</italic> organisms, respectively. Here, as in the case of <mml:math id="jats-math-169" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, the superscript <mml:math id="jats-math-170" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>Z</mml:mi></mml:mrow></mml:mrow></mml:math> is assigned to NF<italic toggle="yes">i</italic> organisms. <mml:math id="jats-math-171" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math> is the fitness of an NF<italic toggle="yes">i</italic> organism, which is multiplied by <mml:math id="jats-math-172" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, the effect of genetic diversity (refer to Equation&#x000a0;(<xref rid="eva70111-disp-0022" ref-type="disp-formula">22</xref>)). Consequently, the untransformed subpopulation size of NU organisms in the (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation is<disp-formula id="eva70111-disp-0019">
<label>(19)</label>
<mml:math id="jats-math-173" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close="]" open="["><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mi>V</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi mathvariant="normal">i</mml:mi></mml:mrow><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where<disp-formula id="eva70111-disp-0020">
<label>(20)</label>
<mml:math id="jats-math-174" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mi>V</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0021">
<label>(21)</label>
<mml:math id="jats-math-175" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mi>Z</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup><mml:mo>+</mml:mo><mml:msub><mml:mi>r</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:msubsup><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>
<mml:math id="jats-math-176" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mi>V</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math> demostrates the probability that an NU organism produces a normal zygote. <mml:math id="jats-math-177" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math> is the same as <mml:math id="jats-math-178" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>U</mml:mi><mml:mn>1</mml:mn><mml:mi>V</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math> for NF<italic toggle="yes">i</italic> organisms. <mml:math id="jats-math-179" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mo>&#x02212;</mml:mo><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mrow></mml:math> reflects the probability that an organism attempts to reproduce by unitary development. <mml:math id="jats-math-180" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> is the survival probability of the NU organisms' juvenile period (<mml:math id="jats-math-181" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x0003c;</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>) (Figure&#x000a0;<xref rid="eva70111-fig-0003" ref-type="fig">3c</xref>). For instance, echinoderm larvae would be exposed to the risk of predation and death due to their small size and immature mobility. <mml:math id="jats-math-182" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> is the same as <mml:math id="jats-math-183" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> for DU organisms. Organisms produced by the fragmentation do not experience such juvenile susceptibility in this model. If a cancerous germ cell succeeds in fertilization, the embryo cannot develop. Note that DU and DF<italic toggle="yes">i</italic> organisms cannot produce NU offspring because they do not possess normal germ cells.</p><p>The fragmentation produces clonal offspring, and the existence of multiple clonal organisms will make them susceptible to infectious disease and cancer (Thomas et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0045" ref-type="bibr">2019</xref>). Let <mml:math id="jats-math-184" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> denote the coefficient that describes the fitness reduction due to the loss of genetic diversity. Given that <mml:math id="jats-math-185" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c1;</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> is the proportion of the NF<italic toggle="yes">i</italic> and DF<italic toggle="yes">i</italic> organisms at the <italic toggle="yes">j</italic>&#x02010;th generation,<disp-formula id="eva70111-disp-0022">
<label>(22)</label>
<mml:math id="jats-math-186" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo linebreak="goodbreak">+</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:msub><mml:mi>&#x003c1;</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mfrac><mml:mn>1</mml:mn><mml:mn>4</mml:mn></mml:mfrac></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>for <mml:math id="jats-math-187" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x0003c;</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>&#x0003c;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>. The concavity of <mml:math id="jats-math-188" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> against <mml:math id="jats-math-189" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003c1;</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> explains that a smaller proportion of clones in the population has a negligible effect on population fitness. However, a higher proportion of clones drastically reduces the fitness of NF<italic toggle="yes">i</italic> and DF<italic toggle="yes">i</italic> organisms (<mml:math id="jats-math-190" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x02264;</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>&#x02264;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mrow></mml:math>). Lower values of <mml:math id="jats-math-191" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> are associated with the pronounced fitness reduction stemming from the genetic homogeneity (Figure&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>).</p><p>The actual subpopulation size of the NU organisms at the subsequent generation (<mml:math id="jats-math-192" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>) should consider the effect of the fluctuations in total population on the untransformed population size (<mml:math id="jats-math-193" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math>) which will be explained later.</p><p>All organisms in a generation are expected to possess defective germ cells. Hence, they can produce DU organisms by unitary development. By the same reasoning as <mml:math id="jats-math-194" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math> was deduced,<disp-formula id="eva70111-disp-0023">
<label>(23)</label>
<mml:math id="jats-math-195" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>W</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mn>1</mml:mn><mml:mo linebreak="goodbreak">&#x02212;</mml:mo><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mfenced><mml:mfenced close="]" open="["><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>V</mml:mi></mml:msup><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mi>V</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>W</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>W</mml:mi></mml:msup><mml:msubsup><mml:mi>U</mml:mi><mml:mn>2</mml:mn><mml:mi>W</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mi>Z</mml:mi></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Q</mml:mi></mml:msubsup><mml:msubsup><mml:mi>U</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mi>i</mml:mi></mml:mrow><mml:mi>Q</mml:mi></mml:msubsup></mml:mrow></mml:mfenced></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>where the asterisk implies that it is an untransformed subpopulation size. The detailed derivation processes are provided in Appendix <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>.</p><p>NF1 organisms in the (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation are produced by NU organisms in the <italic toggle="yes">j</italic>&#x02010;th generation by asexual fragmentation (Figure&#x000a0;<xref rid="eva70111-fig-0004" ref-type="fig">4</xref>).<disp-formula id="eva70111-disp-0024">
<label>(24)</label>
<mml:math id="jats-math-196" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>&#x003d5;</mml:mi><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Similarly, NF(<italic toggle="yes">i</italic>&#x02009;+&#x02009;1) organisms in the (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation are produced by NF<italic toggle="yes">i</italic> organisms in the <italic toggle="yes">j</italic>&#x02010;th generation by asexual fragmentation.<disp-formula id="eva70111-disp-0025">
<label>(25)</label>
<mml:math id="jats-math-197" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>&#x003d5;</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Likewise, DF<italic toggle="yes">i</italic> organisms satisfy the following equations.<disp-formula id="eva70111-disp-0026">
<label>(26)</label>
<mml:math id="jats-math-198" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>Q</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>&#x003d5;</mml:mi><mml:msub><mml:mi>W</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>W</mml:mi></mml:msup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
<disp-formula id="eva70111-disp-0027">
<label>(27)</label>
<mml:math id="jats-math-199" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:mi>&#x003d5;</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Q</mml:mi></mml:msubsup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>By the aforementioned relations, the total untransformed population size of (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation is determined.<disp-formula id="eva70111-disp-0028">
<label>(28)</label>
<mml:math id="jats-math-200" display="block" overflow="scroll"><mml:mrow><mml:mrow><mml:mtable displaystyle="true"><mml:mtr><mml:mtd><mml:msubsup><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">=</mml:mo><mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:msubsup><mml:mi>W</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>j</mml:mi></mml:munderover><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo linebreak="goodbreak">+</mml:mo><mml:munderover><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>j</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:munderover><mml:msubsup><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mrow></mml:math>
</disp-formula>
</p><p>Considering the environmental capacity and to avoid the abrupt change in population size, it was assumed that the ratio of population size at the (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th and <italic toggle="yes">j</italic>&#x02010;th generation is bounded between 0.9391 to 1.08. These bounds are determined by the specific logistic function (<mml:math id="jats-math-201" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00398;</mml:mi></mml:mrow></mml:mrow></mml:math>, Equation&#x000a0;(<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S7</xref>)) designed to prevent rapid fluctuations of populations (Figure&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S2</xref>). The actual subpopulation size at the (<italic toggle="yes">j</italic>&#x02009;+&#x02009;1)&#x02010;th generation was calculated by multiplying the untransformed subpopulation size by <mml:math id="jats-math-202" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00398;</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo>/</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>. For example, <mml:math id="jats-math-203" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x00398;</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo>/</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msubsup><mml:mi>V</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-204" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi mathvariant="normal">&#x00398;</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mi>P</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup><mml:mo>/</mml:mo><mml:msub><mml:mi>P</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:msubsup><mml:mi>W</mml:mi><mml:mrow><mml:mi>j</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math>. The sum of the individual organisms' fitness at the 30th generation was used as the optimization index of the reproduction strategy. The variables are explained in Table&#x000a0;<xref rid="eva70111-tbl-0001" ref-type="table">1</xref>.</p><table-wrap position="float" id="eva70111-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>The explanation of the major variables and abbreviations used in this study.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Variable or abbreviation</th><th align="left" valign="bottom" rowspan="1" colspan="1">Description</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">priSC</td><td align="left" valign="top" rowspan="1" colspan="1">Primordial stem cells (e.g., planarian neoblasts, <italic toggle="yes">Hydra</italic> I&#x02010;cells, 4d lineage of annelids and mollusks, the inner cell mass of mammalian embryo (Solana&#x000a0;<xref rid="eva70111-bib-0042" ref-type="bibr">2013</xref>))</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">APSC</td><td align="left" valign="top" rowspan="1" colspan="1">Adult primordial stem cell</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PGC</td><td align="left" valign="top" rowspan="1" colspan="1">Primordial germ cell</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">GMP</td><td align="left" valign="top" rowspan="1" colspan="1">Germline multipotency program</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-205" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a0;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-206" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x003a8;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-207" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">&#x00393;</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The proportions of normal, defective, and cancerous PGCs/APSCs of an organism after <mml:math id="jats-math-208" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math> times of cell replications</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-209" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-210" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>D</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-211" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>C</mml:mi><mml:mfenced close=")" open="("><mml:mi>t</mml:mi></mml:mfenced></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The proportions of normal, defective, and cancerous somatic cells of an organism after <mml:math id="jats-math-212" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>t</mml:mi></mml:mrow></mml:mrow></mml:math> times of cell replications</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-213" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-214" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-215" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-216" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The transition rates that determine the transformation of normal cells into defective cells (<mml:math id="jats-math-217" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-218" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>) and the transformation of defective cells into cancerous cells (<mml:math id="jats-math-219" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-220" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>). <mml:math id="jats-math-221" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-222" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> represent the transition rates of PGCs/APSCs, and <mml:math id="jats-math-223" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-224" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> represent the transition rates of somatic cells. In addition to mutation rates, the differential growth rate of each cell type can affect the transition rates</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-225" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The probability that the organism reproduces by fragmentation in each reproductive attempt</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-226" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-227" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The subpopulation sizes of the NU and DU organisms at the <italic toggle="yes">j</italic>&#x02010;th generation, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-228" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-229" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The subpopulation sizes of NF<italic toggle="yes">i</italic> and DF<italic toggle="yes">i</italic> organisms at the <italic toggle="yes">j</italic>&#x02010;th generation</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-230" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>V</mml:mi><mml:mi>j</mml:mi><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-231" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>W</mml:mi><mml:mi>j</mml:mi><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-232" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-233" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow><mml:mo>*</mml:mo></mml:msubsup></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The untransformed subpopulation sizes of <mml:math id="jats-math-234" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-235" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-236" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>Z</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-237" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>Q</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>j</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mrow></mml:math>, respectively. Applying the effect of total population fluctuation (Equation&#x000a0;(<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S7</xref>)) determines the actual subpopulation size</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-238" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>V</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-239" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msup><mml:mi>&#x003c9;</mml:mi><mml:mi>W</mml:mi></mml:msup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-240" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Z</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-241" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msubsup><mml:mi>&#x003c9;</mml:mi><mml:mi>i</mml:mi><mml:mi>Q</mml:mi></mml:msubsup></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The fitness of NU, DU, NF<italic toggle="yes">i</italic>, DF<italic toggle="yes">i</italic> organisms, respectively. Here, the superscripts are not numbers, but labels</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-242" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The proliferation index of APSCs which influences the production of somatic cells, cancer risk, and regenerative capability</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-243" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The parameter (power) that determines the fatality of cancer. A small increase in cancer proportion results in significant fitness reduction if <mml:math id="jats-math-244" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> is high</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-245" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-246" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The numbers of cell replications required to obtain maturity for unitary development and fragmentation, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-247" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-248" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The survival rates of NU and DU juvenile organisms developed from the zygote, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-249" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-250" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-251" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The degrees of vertical transmission via fragmentation for normal, defective, and cancerous cells, respectively</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<mml:math id="jats-math-252" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-253" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>r</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>
</td><td align="left" valign="top" rowspan="1" colspan="1">The functionality of normal and defective germ cells that determines their probability of fertilization</td></tr></tbody></table></table-wrap><p>Using the principles of linear algebra, we can mathematically expect how consecutive fragmentations influence the proportion of the cancer cells in the progeny. Suppose that <mml:math id="jats-math-254" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>&#x0003e;</mml:mo><mml:mi>max</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mspace width="0.5em"/><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math> holds. In this condition, consecutive fragmentation results in a higher proportion of offspring (Propositions 1, 2 in Appendix <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>), and fragmentational purging is not allowed (Corollary 1 in Appendix <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>). This implies that the higher propensity of tumor cell transmission via fragmentation (<mml:math id="jats-math-255" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>), higher transition rates (<mml:math id="jats-math-256" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>), and longer time required for the maturity after fragmentation (<mml:math id="jats-math-257" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>) are likely to induce fragmentational accumulation. On the other hand, if <mml:math id="jats-math-258" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>&#x0003e;</mml:mo><mml:mi>max</mml:mi><mml:mfenced close=")" open="(" separators=","><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow><mml:mrow><mml:mspace width="0.5em"/><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>, the proportion of cancerous APSCs in NF<italic toggle="yes">n</italic> organisms converges to a certain nonnegative value as fragmentation is repeated (Proposition 1). If <mml:math id="jats-math-259" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mi>exp</mml:mi><mml:mfenced close="]" open="["><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>&#x0003e;</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, the same argument applies to DF<italic toggle="yes">n</italic> organisms (Proposition 2). Proof, conditions, and specific examples (Examples&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>, <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S2</xref>) of the mathematical arguments are provided in Appendix <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>.</p></sec><sec id="eva70111-sec-0005"><label>2.3</label><title>Computational Analysis</title><p>To analyze the evolutionary dynamics of the diverse fissiparous or budding organisms, models under different sets of parameters were tested. There are three types of models in this study&#x02014;FRPG, FRAC, BINF. Fragmentation under FRAC (fragmentational accumulation) models elevates the proportions of cancerous cells of progeny. Therefore, cancers of organisms accumulate through consecutive fragmentations. Fragmentation under FRPG (fragmentational purging) models reduces the proportions of cancerous cells of progeny. While fragmentation of FRPG and FRAC assumes asymmetric fragmentation or budding, BINF (binary fission) models illustrate binary fission inspired by planarian fission assuming (nearly) homogeneously distributed tumor cells. Accordingly, binary fission in this model postulates <mml:math id="jats-math-260" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> implying that all cells are equitably distributed into two fragments. Unlike asymmetric fragmentation or budding, there is no parent&#x02013;offspring relationship after binary fission: each half becomes the offspring. Thus, two offspring are produced by binary fission rather than a single nascent offspring from budding or asymmetric fragmentation. Since the fragment from binary fission has the same cell composition as the parent, the mature organism should have a higher proportion of cancer cells than the parent (Corollary 2 in Appendix <xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>). As such, for binary fission accompanied by equitable cell distribution, consecutive binary fission elevates the proportions of the cancers across generations, similar to FRAC models.</p><p>FR or UD were appended to the model names depending on which strategy is fitness&#x02010;maximizing, where FR and UD stand for fragmentation and unitary development, respectively. For instance, the model name FRAC&#x02010;UD implies that consecutive fragmentation elevates cancer cell composition and unitary development is the fitness&#x02010;maximizing strategy. The dynamics of the seven models were examined by changing the parameters including juvenile survival probability (<mml:math id="jats-math-261" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-262" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>), frequency (<mml:math id="jats-math-263" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003c4;</mml:mi></mml:mrow></mml:mrow></mml:math>) and severity (<mml:math id="jats-math-264" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b4;</mml:mi></mml:mrow></mml:mrow></mml:math>) of external damage, the effect of genetic diversity (<mml:math id="jats-math-265" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>) (Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S2</xref>). In each model, the inactivation of the fragmentation (<mml:math id="jats-math-266" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math>) implies the absence of the APSCs (<mml:math id="jats-math-267" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math>). In such cases, <mml:math id="jats-math-268" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-269" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003bc;</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> (Equations&#x000a0;<xref rid="eva70111-disp-0001" ref-type="disp-formula">(1)</xref>, <xref rid="eva70111-disp-0002" ref-type="disp-formula">(2)</xref>, <xref rid="eva70111-disp-0003" ref-type="disp-formula">(3)</xref>, <xref rid="eva70111-disp-0004" ref-type="disp-formula">(4)</xref>, <xref rid="eva70111-disp-0005" ref-type="disp-formula">(5)</xref>, <xref rid="eva70111-disp-0006" ref-type="disp-formula">(6)</xref>) solely represent the transition rates of PGCs.</p><p>For each model, five strategies of biased replication fidelity (<mml:math id="jats-math-270" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:math> is either 0.5, 0.75, 1, 1.25, 1.5) were tested. By changing the values of <mml:math id="jats-math-271" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:math> in Equations&#x000a0;(<xref rid="eva70111-disp-0011" ref-type="disp-formula">11</xref>) and (<xref rid="eva70111-disp-0012" ref-type="disp-formula">12</xref>), somatic cells can be intensively protected from the mutation at the cost of elevated mutation of PGCs/APSCs and <italic toggle="yes">vice versa</italic>. APSC proliferability (<mml:math id="jats-math-272" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math>) was varied from 0.1 to 0.7 in steps of 0.1 for each model. Fitness surfaces obtained from different levels of fragmentation prevalence (<mml:math id="jats-math-273" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mrow></mml:math>) and cancer&#x02010;suppression capability (<mml:math id="jats-math-274" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math>) were recorded, along with cancer prevalence.</p><p>FRPG&#x02010;FR model postulates a high degree of fragmentational purging by setting <mml:math id="jats-math-275" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close="]" open="[" separators=",,"><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>5</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-276" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close="]" open="[" separators=","><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>35</mml:mn><mml:mo>,</mml:mo><mml:mn>15</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>. NU and ND organisms suffer fitness reduction (e.g., predation, malnutrition) during the juvenile period that NF<italic toggle="yes">i</italic> and DF<italic toggle="yes">i</italic> organisms do not need to sustain (<mml:math id="jats-math-277" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close="]" open="[" separators=","><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>0.7</mml:mn><mml:mo>,</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>). This model would be pertinent to species whose budding is formed at tumor&#x02010;free regions with long and susceptible larval periods. Other parameters and details are available in the MATLAB codes.</p><p>Throughout diverse values of APSC proliferability in this FRPG&#x02010;FR model, the adoption of fragmentation is advantageous for survival (Video&#x000a0;<xref rid="eva70111-supitem-0002" ref-type="supplementary-material">S1</xref>). The most favorable strategy is to perform fragmentation more frequently than unitary development (<mml:math id="jats-math-278" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi><mml:mo>&#x0003e;</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mrow></mml:math>) with maximized APSC proliferability (<mml:math id="jats-math-279" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:mrow></mml:mrow></mml:math>) and APSC replication fidelity (<mml:math id="jats-math-280" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn></mml:mrow></mml:mrow></mml:math>). As fragmentation became frequent, the corresponding optimal cancer&#x02010;suppression level was released (Figure&#x000a0;<xref rid="eva70111-fig-0005" ref-type="fig">5a</xref>, Video&#x000a0;<xref rid="eva70111-supitem-0002" ref-type="supplementary-material">S1</xref>). It can be interpreted that prevalent fragmentational purging works as a cancer&#x02010;suppression mechanism. Hence, there is less need to sustain the high level of physiologically costly cancer&#x02010;suppression level when fragmentation is prevailing.</p><fig position="float" fig-type="FIGURE" id="eva70111-fig-0005"><label>FIGURE 5</label><caption><p>The results of FRPG&#x02010;FR and FRPG&#x02010;UD model when maximal fitness is achieved. (a) The overall fitness of the populations adopting different reproductive strategies was evaluated across the parameters of the FRPG&#x02010;FR model (Video&#x000a0;<xref rid="eva70111-supitem-0002" ref-type="supplementary-material">S1</xref>). The translucent surface illustrates the overall fitness at the given parameters. Blue dots on the surface mark the maximized fitness for each fragmentation value (<mml:math id="jats-math-281" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi></mml:mrow></mml:mrow></mml:math>) with the corresponding optimal cancer&#x02010;suppression capability (immunity, <mml:math id="jats-math-282" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math>). The red dot on the surface represents the globally maximal fitness on the surface. The black dot represents the maximal fitness when fragmentation is inhibited (<mml:math id="jats-math-283" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003d5;</mml:mi><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:mrow></mml:math>). The projections of maximal points are also marked on the <italic toggle="yes">xy</italic>&#x02010;plane. The globally maximal fitness under <mml:math id="jats-math-284" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:mrow></mml:mrow></mml:math> and <mml:math id="jats-math-285" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>1.5</mml:mn></mml:mrow></mml:mrow></mml:math> outcompetes the globally maximal fitness under other conditions. Such a set of parameters postulates the higher APSC proliferation (<mml:math id="jats-math-286" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math>) and APSC replication fidelity (<mml:math id="jats-math-287" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi></mml:mrow></mml:mrow></mml:math>). Note that optimal immunity in each fragmentation value decreases as fragmentation value increases, as shown by the trend of projected blue markers. (b) The overall fitness of the populations under the FRPG&#x02010;UD model was evaluated (Video&#x000a0;<xref rid="eva70111-supitem-0003" ref-type="supplementary-material">S2</xref>). Note that the configurations of axes are different from (a). Maximal fitness was obtained when the organism did not perform fragmentation with concentrated mutation protection on somatic cells (<mml:math id="jats-math-288" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>s</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mrow></mml:math>). As it was assumed that APSCs are absent in populations that exclusively perform sexual reproduction, <mml:math id="jats-math-289" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b8;</mml:mi></mml:mrow></mml:mrow></mml:math> does not influence the fitness of populations lacking APSCs. (c) The cell composition of the NU and NF<italic toggle="yes">n</italic> organisms with immunity of optimal fitness under the FRPG&#x02010;FR model (the red marker in (a)). Colors represent the proportion of normal, defective, and cancerous cells from the PGC/APSC population (yellow hue) and somatic cells (blue hue). Note that the <italic toggle="yes">y</italic>&#x02010;axis is in the log scale. The composition of the NF<italic toggle="yes">n</italic> organism was marked with the number of consecutive fragmentations (<italic toggle="yes">n</italic>), while the NF0 represents the NU organism. Repeated fragmentations reduce the proportions of the cancerous cells across the generations (fragmentational purging). (d) The average cancer prevalence in the population under the conditions that are marked in (a). The blue, red, and black markers in this panel match the conditions of those markers in (a). A higher rate of fragmentation leads to lower average cancer prevalence. (e) Same as (d) for the FRPG&#x02010;UD model of (b). The light blue markers imply that fitness on that condition is lower than the fitness obtained from unitary development. (f) Color legend for panel (c).</p></caption><graphic xlink:href="EVA-18-e70111-g002" position="anchor" id="jats-graphic-9"/></fig><p>For the FRPG&#x02010;UD model, the organisms are less inflicted by cancer because the exponent of the composition&#x02010;to&#x02010;fitness function (<mml:math id="jats-math-290" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> in Equation&#x000a0;(<xref rid="eva70111-disp-0015" ref-type="disp-formula">15</xref>)) was modified from <mml:math id="jats-math-291" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:mrow></mml:math> of the FRPG&#x02010;FR model to <mml:math id="jats-math-292" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi><mml:mo>=</mml:mo><mml:mn>1.1</mml:mn></mml:mrow></mml:mrow></mml:math>. By diminishing the exponent, an increase in cancer cells becomes less detrimental to organismal fitness. Accordingly, the advantage of fragmentational purging becomes less prominent. The external damage is less severe (<mml:math id="jats-math-293" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mfenced close="]" open="[" separators=","><mml:mi>&#x003c4;</mml:mi><mml:mi>&#x003b4;</mml:mi></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced close="]" open="["><mml:mrow><mml:mn>0.3</mml:mn><mml:mo>,</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math> in Equation&#x000a0;(<xref rid="eva70111-disp-0016" ref-type="disp-formula">16</xref>)), while the loss of genetic diversity imposes higher fitness reduction in this model (<mml:math id="jats-math-294" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.1</mml:mn></mml:mrow></mml:mrow></mml:math> in Equation&#x000a0;(<xref rid="eva70111-disp-0022" ref-type="disp-formula">22</xref>)). Risk during the juvenile period (<mml:math id="jats-math-295" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-296" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>) and fragmentational values (<mml:math id="jats-math-297" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-298" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-299" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>) were modified as well. As a result, though consecutive fragmentation lowers the cancer composition (fragmentational purging), the optimal strategy is to exclusively perform sexual reproduction (Figure&#x000a0;<xref rid="eva70111-fig-0005" ref-type="fig">5b</xref>). This result indicates that fragmentational purging does not ensure the adoption of fragmentation as an evolutionarily stable strategy. Furthermore, as a general tendency, higher values of fragmentation in FRPG models result in lower cancer prevalence under a wide range of conditions (Figure&#x000a0;<xref rid="eva70111-fig-0005" ref-type="fig">5d,e</xref>).</p><p>On the other hand, consecutive fragmentation elevates cancer composition in the FRAC&#x02010;UD model. Under this model, it is optimal to exclude fragmentation with concentrated mutation protection on somatic cells (Figure&#x000a0;<xref rid="eva70111-fig-0006" ref-type="fig">6b</xref>). By adopting exclusive sexual reproduction, the cancer prevalence can be suppressed to low values compared to those obtained from the corresponding fragmentation&#x02010;involved strategies (Figure&#x000a0;<xref rid="eva70111-fig-0006" ref-type="fig">6e</xref>).</p><fig position="float" fig-type="FIGURE" id="eva70111-fig-0006"><label>FIGURE 6</label><caption><p>The results of FRAC&#x02010;FR and FRAC&#x02010;UD model when maximal fitness is achieved. (a) Under the FRAC&#x02010;FR model (Video&#x000a0;<xref rid="eva70111-supitem-0004" ref-type="supplementary-material">S3</xref>), performing fragmentation with maximal APSC proliferability and elevated replication fidelity in APSCs resulted in globally maximal fitness. (b) Under the FRAC&#x02010;UD model (Video&#x000a0;<xref rid="eva70111-supitem-0005" ref-type="supplementary-material">S4</xref>), sexual reproduction without fragmentation resulted in globally maximal fitness. (c) The cell composition of the NU and NF<italic toggle="yes">n</italic> organisms under immunity of optimal fitness from the FRAC&#x02010;FR model (the red marker in (a)). Unlike FRPG models, the proportion of cancer rises as consecutive fragmentation is repeated. (d) The average cancer prevalence in the population under the conditions that are marked in (a). Due to the fragmentational accumulation, the higher fragmentation rates induce a higher cancer prevalence. (e) The average cancer prevalence in the population under the conditions that are marked in (b).</p></caption><graphic xlink:href="EVA-18-e70111-g003" position="anchor" id="jats-graphic-11"/></fig><p>If there is a significant survival risk during the juvenile period and external damage is severe, fragmentation can be selected for though consecutive fragmentation raises the cancer composition, as evidenced by results of the FRAC&#x02010;FR (Figure&#x000a0;<xref rid="eva70111-fig-0006" ref-type="fig">6a</xref>). Unlike FRPG models, higher fragmentation in FRAC models leads to higher cancer prevalence at the optimized cancer&#x02010;suppression level (Figure&#x000a0;<xref rid="eva70111-fig-0006" ref-type="fig">6d,e</xref>).</p><p>Different conditions were implemented in BINF&#x02010;FRa and BINF&#x02010;FRb. BINF&#x02010;FRa is characterized by the prevalent external damage and the low survival rate of juvenile organisms established from unitary development. Additionally, it was assumed that loss of genetic diversity stemming from asexual reproduction imposes mild fitness reduction (<mml:math id="jats-math-300" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0.7</mml:mn></mml:mrow></mml:mrow></mml:math>). As a result, fragmentation is favored in this model (Video&#x000a0;<xref rid="eva70111-supitem-0006" ref-type="supplementary-material">S5</xref>).</p><p>Due to the modified fitness function (changes in <mml:math id="jats-math-301" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>N</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-302" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>D</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-303" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>&#x003b1;</mml:mi><mml:mi>C</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-304" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>&#x003b5;</mml:mi></mml:mrow></mml:mrow></mml:math> of Equation&#x000a0;(<xref rid="eva70111-disp-0015" ref-type="disp-formula">15</xref>), Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S2</xref>), the cancer does not dramatically reduce organismal fitness under the BINF&#x02010;FRb model. In this model, fragmentation is favored with concentrated replication fidelity on APSCs (Video&#x000a0;<xref rid="eva70111-supitem-0007" ref-type="supplementary-material">S6</xref>). Results of BINF&#x02010;FRa and BINF&#x02010;FRb illustrate two possible evolutionary pressures for the adoption of binary fission.</p><p>Reduced risk during juvenility, prominent vulnerability resulting from the loss of genetic diversity, and infrequent external damage lead to dominance of unitary development excluding fragmentation, as supported by BINF&#x02010;UD (Video&#x000a0;<xref rid="eva70111-supitem-0008" ref-type="supplementary-material">S7</xref>). All model results are summarized in Videos&#x000a0;<xref rid="eva70111-supitem-0002" ref-type="supplementary-material">[Link]</xref>, <xref rid="eva70111-supitem-0003" ref-type="supplementary-material">[Link]</xref>, <xref rid="eva70111-supitem-0004" ref-type="supplementary-material">[Link]</xref>, <xref rid="eva70111-supitem-0005" ref-type="supplementary-material">[Link]</xref>, <xref rid="eva70111-supitem-0006" ref-type="supplementary-material">[Link]</xref>, <xref rid="eva70111-supitem-0007" ref-type="supplementary-material">[Link]</xref>, <xref rid="eva70111-supitem-0008" ref-type="supplementary-material">[Link]</xref>, and specific model parameters are presented in Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S2</xref>.</p></sec></sec><sec sec-type="discussion" id="eva70111-sec-0006"><label>3</label><title>Discussion</title><p>Although fragmentation (including budding) is not a common mode of reproduction in animals, a comparative analysis of cancer susceptibility and cancer suppression therein would expand our understanding of cancer from an evolutionary perspective. Considering the existence of the APSCs, verified or presumptive, in fragmentational species, the APSCs could be the prerequisite for performing fissiparity or budding. The APSCs are associated with high regenerative capability, while sharing multiple essential traits with cancer stem cells.</p><p>Two counterbalancing effects of carcinogenesis are involved in the reproduction by fragmentation. Although fragmentation explicitly delivers the parental somatic cancer cells to progeny, it can reduce the number of cell replications (and accordingly time) required to reach maturity. To simplify the situation, suppose that all cells are viable until maturity. Given that the cell number at maturity is <mml:math id="jats-math-305" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, a zygote and its progeny cells need to replicate <mml:math id="jats-math-306" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>log</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>N</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> times to reach maturity. Given that the offspring contains <mml:math id="jats-math-307" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math> cells after fragmentation (<mml:math id="jats-math-308" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x0003c;</mml:mo><mml:mi>r</mml:mi><mml:mo>&#x02264;</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mrow></mml:math>), the required number of the replication is <mml:math id="jats-math-309" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>log</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mi>r</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>M</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mrow></mml:math>. For example, if a mature organism is composed of 1024 (=&#x02009;2<sup>10</sup>) cells, then a zygote needs to replicate 10 times to reach that size. On the other hand, if a detached fragment contains 128 (=&#x02009;2<sup>7</sup> where <mml:math id="jats-math-310" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>8</mml:mn></mml:mrow></mml:mrow></mml:math>) cells, each cell needs to divide 3 times. The reduction in replication number culminates in binary fission (<mml:math id="jats-math-311" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>r</mml:mi><mml:mo>=</mml:mo><mml:mn>0.5</mml:mn></mml:mrow></mml:mrow></mml:math>). Under this simplified framework, only a single replication of each cell suffices to establish an integral organism after binary fission. Even though binary fission assuming equitable cell distribution will intensify the cancer risk of offspring (Corollary 2), the time required for maturation after fission will be substantially reduced than the maturation from a zygote (Ivankovic et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0020" ref-type="bibr">2019</xref>; Stocchino and Manconi&#x000a0;<xref rid="eva70111-bib-0044" ref-type="bibr">2013</xref>). By all means, this postulation does not consider the lifespan of cells and the precise developmental process toward maturity. Nonetheless, it is indisputable that offspring produced via fragmentation benefit from fewer cell replications or shorter maturation periods (implemented in the models by <mml:math id="jats-math-312" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>U</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-313" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-314" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-315" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>). As the number of stem cell replications is an evident risk factor for cancer (Tomasetti and Vogelstein&#x000a0;<xref rid="eva70111-bib-0048" ref-type="bibr">2015</xref>), fragmentation may reduce the offspring's cancer risk.</p><p>How cancerous or defective cells are transmitted to progeny combined with the reduced number of cell replications determines whether fragmentation elevates the cancer prevalence of the progeny. Depending on such conditions, consecutive fragmentation may suppress or raise the cancer prevalence (fragmentational purging or accumulation) as investigated in Propositions 1, 2, and Corollary 1. Mathematical analyses imply that a lower rate of vertical cancer transmission (<mml:math id="jats-math-316" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>) and the reduced number of cell replications after fragmentation (<mml:math id="jats-math-317" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>T</mml:mi><mml:mi>F</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>) are likely to induce fragmentational purging. Frequent fragmentational purging functions to suppress cancer so that the burden of physiological cancer suppression is relieved (Figure&#x000a0;<xref rid="eva70111-fig-0005" ref-type="fig">5a</xref>, Video&#x000a0;<xref rid="eva70111-supitem-0002" ref-type="supplementary-material">S1</xref>). However, fragmentational purging does not ensure the adoption of fragmentation (FRPG&#x02010;UD), nor does fragmentational accumulation necessarily prevent fragmentation (FPAC&#x02010;FR). Despite the fragmentational accumulation, a low survival rate during juvenility (<mml:math id="jats-math-318" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>V</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>, <mml:math id="jats-math-319" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi mathvariant="normal">&#x00394;</mml:mi><mml:mi>W</mml:mi></mml:msub></mml:mrow></mml:mrow></mml:math>) facilitates the adoption of fragmentation as shown in FRAC&#x02010;FR and BINF&#x02010;FRa models. In contrast, the benignity of the tumor was postulated in the FRPG&#x02010;UD model, implying that fragmentational purging may not be a merit if the tumor is not a serious threat.</p><p>Another consequence of the fragmentation is the loss of genetic diversity. Sexual reproduction allows the production of offspring with diversified traits, endowing adaptive advantage under changing environments (Becks and Agrawal&#x000a0;<xref rid="eva70111-bib-0003" ref-type="bibr">2012</xref>; B&#x000fc;rger&#x000a0;<xref rid="eva70111-bib-0007" ref-type="bibr">1999</xref>). Deleterious mutations can be eliminated during the course of sexual reproduction (Muller&#x000a0;<xref rid="eva70111-bib-0035" ref-type="bibr">1964</xref>). Particularly, sexual reproduction could confer protection from horizontally transmissible cancers (Thomas et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0045" ref-type="bibr">2019</xref>). This factor was implemented in the model by changing the coefficient <mml:math id="jats-math-320" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>b</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> in Equation&#x000a0;(<xref rid="eva70111-disp-0022" ref-type="disp-formula">22</xref>).</p><p>A certain <italic toggle="yes">Hydra</italic> species, <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Hydra oligactis</italic>
</styled-content> and <styled-content style="fixed-case" toggle="no">
<italic toggle="no">P. robusta</italic>
</styled-content>, spontaneously develop tumor (Boutry et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0005" ref-type="bibr">2023</xref>), but not all progeny budded from tumoral parents have transmitted tumor (Boutry et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0006" ref-type="bibr">2022</xref>). Even in the presence of tumors, they still can produce their progeny sexually or asexually (Tissot et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0046" ref-type="bibr">2024</xref>; Domazet&#x02010;Lo&#x00161;o et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0011" ref-type="bibr">2014</xref>; Boutry et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0006" ref-type="bibr">2022</xref>). Consecutive vertical cancer transmission of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">H. oligactis</italic>
</styled-content> appears to elevate the cancer proportion of the offspring (Tissot et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0046" ref-type="bibr">2024</xref>), comparable to fragmentational accumulation. Furthermore, the bearing of tumors may alter the reproductive strategy of the host <italic toggle="yes">Hydra</italic> such as reproductive age or budding rates (Tissot et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0046" ref-type="bibr">2024</xref>; Boutry et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0006" ref-type="bibr">2022</xref>). Similarly, tumoral planaria still can reproduce asexually (Lange&#x000a0;<xref rid="eva70111-bib-0028" ref-type="bibr">1966</xref>).</p><p>Consecutive fragmentation mediated by binary fission postulating equal distribution of cells (<mml:math id="jats-math-321" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math>) is expected to elevate cancer composition throughout generations (Corollary 2). Despite this drawback, results from BINF&#x02010;FRa and BINF&#x02010;FRb illustrate possible evolutionary pressures for adopting binary fission. In both models, maximal fitness is achieved when APSCs are strongly protected from mutation at the cost of somatic cell mutation risk. In accordance with this finding, stem cells of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Schmidtea mediterranea</italic>
</styled-content> are selectively protected from carcinogenesis (Van Roten et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0052" ref-type="bibr">2018</xref>; Mihaylova et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0033" ref-type="bibr">2018</xref>). However, within the same species of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">S. mediterranea</italic>
</styled-content>, different strains exhibit different modes of sexual and asexual reproduction strategies (Zayas et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0054" ref-type="bibr">2005</xref>). Moreover, exposure to cadmium has different effects on planarian species. For example, <styled-content style="fixed-case" toggle="no">
<italic toggle="no">S. mediterranea</italic>
</styled-content> is resistant to cadmium&#x02010;induced carcinogenesis, while <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Dugesia dorotocephala</italic>
</styled-content> and <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Dugesia tigrina</italic>
</styled-content> are vulnerable (Van Roten et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0052" ref-type="bibr">2018</xref>). While it was assumed in the model that cells are equitably distributed to the two fragments via binary fission, either of the fragments could be purged as the planarian tumors of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Dugesia etrusca</italic>
</styled-content> and <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Dugesia ilvana</italic>
</styled-content> are usually located at the posterior tip of the body (Lange&#x000a0;<xref rid="eva70111-bib-0028" ref-type="bibr">1966</xref>). As a result of the transverse fission, the progeny developed from the anterior fragment was not afflicted by the parental tumor (Lange&#x000a0;<xref rid="eva70111-bib-0028" ref-type="bibr">1966</xref>), reminiscent of fragmentational purging. In this case, the FRPG&#x02010;FR model assuming <mml:math id="jats-math-322" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:msub><mml:mi>f</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>&#x0003e;</mml:mo><mml:msub><mml:mi>f</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mrow></mml:math> for the anterior fragment would be suitable to describe the evolutionary dynamics of those planarians.</p><p>Though comprehensive data is not available, I examined the cancer prevalence and regeneration capability of diverse animal (Metazoa) taxa which perform fragmentation after maturation. Intriguingly, while cancer is a prevailing disease among the wide range of animal taxa (Aktipis et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0001" ref-type="bibr">2015</xref>), there is no evidence of spontaneous cancer under natural conditions in some fissiparous or budding animals including starfish, sea anemone, and acorn worms (Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>). It is also noteworthy that sponges and placozoans do not develop tumors even after exposure to high radiation (Fortunato et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0013" ref-type="bibr">2021</xref>, <xref rid="eva70111-bib-0014" ref-type="bibr">2025</xref>). On the other hand, planarians, <italic toggle="yes">Hydra</italic>, corals, and brittle stars are susceptible to cancer though they perform fragmentation (Aktipis et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0001" ref-type="bibr">2015</xref>).</p><p>The proposed model can provide a possible explanation for different degrees of cancer susceptibility in fragmentational animals depending on cell replication number and degree of vertical cancer transmission rates which are quantitatively measurable (Tissot et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0046" ref-type="bibr">2024</xref>; Domazet&#x02010;Lo&#x00161;o et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0011" ref-type="bibr">2014</xref>). Cancer&#x02010;suppression capability (<mml:math id="jats-math-323" display="inline" overflow="scroll"><mml:mrow><mml:mrow><mml:mi>I</mml:mi></mml:mrow></mml:mrow></mml:math> in Equations&#x000a0;(<xref rid="eva70111-disp-0011" ref-type="disp-formula">11</xref>), (<xref rid="eva70111-disp-0012" ref-type="disp-formula">12</xref>)) can be investigated as well. For example, many animals in which no sign of cancer was reported such as starfish (Kicha et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0025" ref-type="bibr">2010</xref>), sponges (Calcabrini et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0008" ref-type="bibr">2017</xref>), annelids (Macedo et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0030" ref-type="bibr">2021</xref>), sea anemones (Soletti et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0043" ref-type="bibr">2008</xref>) produce diverse anticancer substances.</p><p>Obviously, the absence of reports on cancer could be the consequence of insufficient observation: subsequent investigation may identify the naturally occurring tumors in those animals that are reportedly cancer&#x02010;resistant. Interspecific variation complicates the generalization of the relationship between fragmentation and cancer susceptibility. Further investigation is required to clarify how modes of reproduction influence the evolution of cancer (Table&#x000a0;<xref rid="eva70111-tbl-0002" ref-type="table">2</xref>).</p><table-wrap position="float" id="eva70111-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Future research questions.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Do animals that can perform fragmentation or budding have adult primordial stem cells (APSCs)?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Are fissiparous animals generally robust against cancer?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">What is the required number of cell replications after fragmentation compared to the unitary development?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">How much of the parental cancer cells are included in the fragment for asexual reproduction?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Are APSCs heavily protected from mutation (compared to somatic bystander cells)?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Does mutation in APSCs lead to carcinogenesis in fragmentational animals?</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Does possession of APSCs inhibit a higher degree of differentiation across animal taxa?</td></tr></tbody></table></table-wrap><p>The high degree of differentiation ensuring diverse cell types may not reliably coincide with the multipotency of the adult cells including the capability to dedifferentiate (epimorphosis) or transdifferentiate (morphallaxis) (Cho et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0010" ref-type="bibr">2024</xref>). Corroborating to this speculation, the organisms that can perform fragmentation up to date exhibit relatively simple body plans composed of a minor number of cell types (Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>). Namely, possession of APSCs at the cost of sophisticated cell differentiation could be a suitable strategy for certain animals.</p><p>Extensive differentiation requires elaborate developmental mechanisms, the mutation at which would impose oncogenic transformation (cell specialization trade&#x02010;offs <italic toggle="yes">sensu</italic> Hammarlund et&#x000a0;al.&#x000a0;(<xref rid="eva70111-bib-0018" ref-type="bibr">2020</xref>)). As the number of the molecular pathways of the cells that control the proliferation and development increases, the risk of oncogenic mutations at either of those pathways would accordingly increase (Jacques et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0022" ref-type="bibr">2022</xref>). If all highly differentiated somatic cells are endowed with multipotency including transdifferentiation or dedifferentiation, one may speculate that the risk of cancer will dramatically escalate (Cho et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0010" ref-type="bibr">2024</xref>; Jacques et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0022" ref-type="bibr">2022</xref>). This would be the reason that animals with complex body plans are incapable of performing fragmentation and their regenerative capability is limited. <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Polypodium hydriforme</italic>
</styled-content> could be an example of such a trade&#x02010;off between differentiation and regeneration (Table&#x000a0;<xref rid="eva70111-supitem-0001" ref-type="supplementary-material">S1</xref>). Compared to other cnidarians, <styled-content style="fixed-case" toggle="no">
<italic toggle="no">P. hydriforme</italic>
</styled-content> has highly differentiated cell types (Raikova&#x000a0;<xref rid="eva70111-bib-0038" ref-type="bibr">2008</xref>). Though <styled-content style="fixed-case" toggle="no">
<italic toggle="no">P. hydriforme</italic>
</styled-content> can reproduce by fission, this animal does not exhibit remarkable regeneration (Raikova&#x000a0;<xref rid="eva70111-bib-0038" ref-type="bibr">2008</xref>).</p><p>To my knowledge, this is the first analytical model that investigates the link between asexual reproduction via fragmentation and evolutionary dynamics of cancer susceptibility by incorporating the number of cell replications, influence of APSCs, and vertical transmission extent of cancer cells. This study demonstrates various evolutionary pathways that fragmentation can be selected for and the corresponding cancer prevalence. Further examination of fissiparous or budding animals would verify the validity of the proposed model (Table&#x000a0;<xref rid="eva70111-tbl-0002" ref-type="table">2</xref>) and provide insights for medical applications.</p><p>Germ cells, stem cells, and cancer stem cells have multiple features in common, particularly under the perspective of germline multipotent programs. Regeneration, cell type diversification, and oncogenicity would be accordingly intertwined (Jacques et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0022" ref-type="bibr">2022</xref>). Mammals would have favored complex body plans including neural systems by releasing regeneration, while <italic toggle="yes">Hydra</italic> would have pursued regeneration and budding at the cost of highly specialized cells. This perspective enables us to appreciate cancer as the outcome of the evolutionary trade&#x02010;offs (Jacqueline et&#x000a0;al.&#x000a0;<xref rid="eva70111-bib-0021" ref-type="bibr">2017</xref>).</p></sec><sec sec-type="COI-statement" id="eva70111-sec-0007"><title>Conflicts of Interest</title><p>The author declares no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="eva70111-supitem-0001" position="float" content-type="local-data"><caption><p>
Appendix S1.
</p></caption><media xlink:href="EVA-18-e70111-s001.pdf"/></supplementary-material><supplementary-material id="eva70111-supitem-0002" position="float" content-type="local-data"><caption><p>
<bold>Video S1.</bold> Results of FRPG&#x02010;FR model.</p></caption><media xlink:href="EVA-18-e70111-s008.gif"/></supplementary-material><supplementary-material id="eva70111-supitem-0003" position="float" content-type="local-data"><caption><p>
<bold>Video S2.</bold> Results of FRPG&#x02010;UD model.</p></caption><media xlink:href="EVA-18-e70111-s005.gif"/></supplementary-material><supplementary-material id="eva70111-supitem-0004" position="float" content-type="local-data"><caption><p>
<bold>Video S3.</bold> Results of FRAC&#x02010;FR model.</p></caption><media xlink:href="EVA-18-e70111-s006.gif"/></supplementary-material><supplementary-material id="eva70111-supitem-0005" position="float" content-type="local-data"><caption><p>
<bold>Video S4.</bold> Results of FRAC&#x02010;UD model.</p></caption><media xlink:href="EVA-18-e70111-s003.gif"/></supplementary-material><supplementary-material id="eva70111-supitem-0006" position="float" content-type="local-data"><caption><p>
<bold>Video S5.</bold> Results of BINF&#x02010;FRa model.</p></caption><media xlink:href="EVA-18-e70111-s007.gif"/></supplementary-material><supplementary-material id="eva70111-supitem-0007" position="float" content-type="local-data"><caption><p>
<bold>Video S6.</bold> Results of BINF&#x02010;FRb model.</p></caption><media xlink:href="EVA-18-e70111-s002.gif"/></supplementary-material><supplementary-material id="eva70111-supitem-0008" position="float" content-type="local-data"><caption><p>
<bold>Video S7.</bold> Results of BINF&#x02010;UD model.</p></caption><media xlink:href="EVA-18-e70111-s004.gif"/></supplementary-material></sec></body><back><sec sec-type="data-availability" id="eva70111-sec-0009"><title>Data Availability Statement</title><p>The code for performing the computational analysis in this study is provided in Zenodo: <ext-link xlink:href="https://zenodo.org/records/12789477" ext-link-type="uri" specific-use="software is-supplemented-by">https://zenodo.org/records/12789477</ext-link>.</p></sec><ref-list content-type="cited-references" id="eva70111-bibl-0001"><title>References</title><ref id="eva70111-bib-0001"><mixed-citation publication-type="journal" id="eva70111-cit-0001">
<string-name>
<surname>Aktipis</surname>, <given-names>A. C.</given-names>
</string-name>, <string-name>
<given-names>A. M.</given-names>
<surname>Boddy</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Jansen</surname>
</string-name>, et&#x000a0;al. <year>2015</year>. &#x0201c;<article-title>Cancer Across the Tree of Life: Cooperation and Cheating in Multicellularity</article-title>.&#x0201d; <source>Philosophical Transactions of the Royal Society, B: Biological Sciences</source>
<volume>370</volume>: <elocation-id>20140219</elocation-id>.</mixed-citation></ref><ref id="eva70111-bib-0002"><mixed-citation publication-type="journal" id="eva70111-cit-0002">
<string-name>
<surname>&#x000c1;lvarez&#x02010;Campos</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Garc&#x000ed;a&#x02010;Castro</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Emili</surname>
</string-name>, et&#x000a0;al. <year>2024</year>. &#x0201c;<article-title>Annelid Adult Cell Type Diversity and Their Pluripotent Cellular Origins</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>15</volume>: <elocation-id>3194</elocation-id>.</mixed-citation></ref><ref id="eva70111-bib-0003"><mixed-citation publication-type="journal" id="eva70111-cit-0003">
<string-name>
<surname>Becks</surname>, <given-names>L.</given-names>
</string-name>, and <string-name>
<given-names>A. F.</given-names>
<surname>Agrawal</surname>
</string-name>. <year>2012</year>. &#x0201c;<article-title>The Evolution of Sex Is Favoured During Adaptation to New Environments</article-title>.&#x0201d; <source>PLoS Biology</source>
<volume>10</volume>: <elocation-id>e1001317</elocation-id>.<pub-id pub-id-type="pmid">22563299</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0004"><mixed-citation publication-type="journal" id="eva70111-cit-0004">
<string-name>
<surname>Belov</surname>, <given-names>K.</given-names>
</string-name>
<year>2011</year>. &#x0201c;<article-title>The Role of the Major Histocompatibility Complex in the Spread of Contagious Cancers</article-title>.&#x0201d; <source>Mammalian Genome</source>
<volume>22</volume>: <fpage>83</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">20963591</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0005"><mixed-citation publication-type="journal" id="eva70111-cit-0005">
<string-name>
<surname>Boutry</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Buysse</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tissot</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>Spontaneously Occurring Tumors in Different Wild&#x02010;Derived Strains of Hydra</article-title>.&#x0201d; <source>Scientific Reports</source>
<volume>13</volume>: <fpage>7449</fpage>.<pub-id pub-id-type="pmid">37156860</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0006"><mixed-citation publication-type="journal" id="eva70111-cit-0006">
<string-name>
<surname>Boutry</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Tissot</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Mekaoui</surname>
</string-name>, et&#x000a0;al. <year>2022</year>. &#x0201c;<article-title>Tumors Alter Life History Traits in the Freshwater Cnidarian, <italic toggle="yes">Hydra oligactis</italic>
</article-title>.&#x0201d; <source>iScience</source>
<volume>25</volume>, no. <issue>10</issue>: <elocation-id>105034</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.isci.2022.105034</pub-id>.<pub-id pub-id-type="pmid">36147948</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0007"><mixed-citation publication-type="journal" id="eva70111-cit-0007">
<string-name>
<surname>B&#x000fc;rger</surname>, <given-names>R.</given-names>
</string-name>
<year>1999</year>. &#x0201c;<article-title>Evolution of Genetic Variability and the Advantage of Sex and Recombination in Changing Environments</article-title>.&#x0201d; <source>Genetics</source>
<volume>153</volume>: <fpage>1055</fpage>&#x02013;<lpage>1069</lpage>.<pub-id pub-id-type="pmid">10511578</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0008"><mixed-citation publication-type="journal" id="eva70111-cit-0008">
<string-name>
<surname>Calcabrini</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Catanzaro</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Bishayee</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Turrini</surname>
</string-name>, and <string-name>
<given-names>C.</given-names>
<surname>Fimognari</surname>
</string-name>. <year>2017</year>. &#x0201c;<article-title>Marine Sponge Natural Products With Anticancer Potential: An Updated Review</article-title>.&#x0201d; <source>Marine Drugs</source>
<volume>15</volume>: <elocation-id>310</elocation-id>.<pub-id pub-id-type="pmid">29027954</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0009"><mixed-citation publication-type="journal" id="eva70111-cit-0009">
<string-name>
<surname>Cheung</surname>, <given-names>T. H.</given-names>
</string-name>, and <string-name>
<given-names>T. A.</given-names>
<surname>Rando</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Molecular Regulation of Stem Cell Quiescence</article-title>.&#x0201d; <source>Nature Reviews Molecular Cell Biology</source>
<volume>14</volume>: <fpage>329</fpage>&#x02013;<lpage>340</lpage>.<pub-id pub-id-type="pmid">23698583</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0010"><mixed-citation publication-type="journal" id="eva70111-cit-0010">
<string-name>
<surname>Cho</surname>, <given-names>C. J.</given-names>
</string-name>, <string-name>
<given-names>J. W.</given-names>
<surname>Brown</surname>
</string-name>, and <string-name>
<given-names>J. C.</given-names>
<surname>Mills</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Origins of Cancer: Ain't It Just Mature Cells Misbehaving?</article-title>&#x0201d; <source>EMBO Journal</source>
<volume>43</volume>: <fpage>2530</fpage>&#x02013;<lpage>2551</lpage>.<pub-id pub-id-type="pmid">38773319</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0011"><mixed-citation publication-type="journal" id="eva70111-cit-0011">
<string-name>
<surname>Domazet&#x02010;Lo&#x00161;o</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Klimovich</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Anokhin</surname>
</string-name>, et&#x000a0;al. <year>2014</year>. &#x0201c;<article-title>Naturally Occurring Tumours in the Basal Metazoan <italic toggle="yes">Hydra</italic>
</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>5</volume>: <fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0012"><mixed-citation publication-type="journal" id="eva70111-cit-0012">
<string-name>
<surname>Doonan</surname>, <given-names>J. H.</given-names>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Sablowski</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>Walls Around Tumours&#x02014;Why Plants Do Not Develop Cancer</article-title>.&#x0201d; <source>Nature Reviews Cancer</source>
<volume>10</volume>: <fpage>794</fpage>&#x02013;<lpage>802</lpage>.<pub-id pub-id-type="pmid">20966923</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0013"><mixed-citation publication-type="journal" id="eva70111-cit-0013">
<string-name>
<surname>Fortunato</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Fleming</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Aktipis</surname>
</string-name>, and <string-name>
<given-names>C. C.</given-names>
<surname>Maley</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Upregulation of DNA Repair Genes and Cell Extrusion Underpin the Remarkable Radiation Resistance of <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Trichoplax adhaerens</italic>
</styled-content>
</article-title>.&#x0201d; <source>PLoS Biology</source>
<volume>19</volume>: <elocation-id>e3001471</elocation-id>.<pub-id pub-id-type="pmid">34788294</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0014"><mixed-citation publication-type="journal" id="eva70111-cit-0014">
<string-name>
<surname>Fortunato</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Taylor</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Scirone</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Seyedi</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Aktipis</surname>
</string-name>, and <string-name>
<given-names>C. C.</given-names>
<surname>Maley</surname>
</string-name>. <year>2025</year>. &#x0201c;<article-title>
<italic toggle="yes">Tethya</italic>
<italic toggle="yes">w</italic>
<italic toggle="yes">ilhelma</italic> (Porifera) is Highly Resistant to Radiation Exposure and Possibly Cancer</article-title>.&#x0201d; <source>Biology (Basel)</source>
<volume>14</volume>: <fpage>171</fpage>.<pub-id pub-id-type="pmid">40001939</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0015"><mixed-citation publication-type="journal" id="eva70111-cit-0015">
<string-name>
<surname>Fujita</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Takahashi</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Kumano</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Kuranaga</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Miura</surname>
</string-name>, and <string-name>
<given-names>Y. I.</given-names>
<surname>Nakajima</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Distinct Stem&#x02010;Like Cell Populations Facilitate Functional Regeneration of the <italic toggle="yes">Cladonema</italic> Medusa Tentacle</article-title>.&#x0201d; <source>PLoS Biology</source>
<volume>21</volume>: <elocation-id>e3002435</elocation-id>.<pub-id pub-id-type="pmid">38127832</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0016"><mixed-citation publication-type="journal" id="eva70111-cit-0016">
<string-name>
<surname>Garcia&#x02010;Borja</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Siegl</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Mateu</surname>
</string-name>, et&#x000a0;al. <year>2024</year>. &#x0201c;<article-title>Critical Appraisal of the piRNA&#x02010;PIWI Axis in Cancer and Cancer Stem Cells</article-title>.&#x0201d; <source>Biomarker Research</source>
<volume>12</volume>: <fpage>15</fpage>.<pub-id pub-id-type="pmid">38303021</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0017"><mixed-citation publication-type="journal" id="eva70111-cit-0017">
<string-name>
<surname>Grosberg</surname>, <given-names>R. K.</given-names>
</string-name>, and <string-name>
<given-names>R. R.</given-names>
<surname>Strathmann</surname>
</string-name>. <year>1998</year>. &#x0201c;<article-title>One Cell, Two Cell, Red Cell, Blue Cell: The Persistence of a Unicellular Stage in Multicellular Life Histories</article-title>.&#x0201d; <source>Trends in Ecology &#x00026; Evolution</source>
<volume>13</volume>: <fpage>112</fpage>&#x02013;<lpage>116</lpage>.<pub-id pub-id-type="pmid">21238226</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0018"><mixed-citation publication-type="journal" id="eva70111-cit-0018">
<string-name>
<surname>Hammarlund</surname>, <given-names>E. U.</given-names>
</string-name>, <string-name>
<given-names>S. R.</given-names>
<surname>Amend</surname>
</string-name>, and <string-name>
<given-names>K. J.</given-names>
<surname>Pienta</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>The Issues With Tissues: The Wide Range of Cell Fate Separation Enables the Evolution of Multicellularity and Cancer</article-title>.&#x0201d; <source>Medical Oncology</source>
<volume>37</volume>: <fpage>62</fpage>.<pub-id pub-id-type="pmid">32535731</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0019"><mixed-citation publication-type="journal" id="eva70111-cit-0019">
<string-name>
<surname>Hulett</surname>, <given-names>R. E.</given-names>
</string-name>, <string-name>
<given-names>J. O.</given-names>
<surname>Kimura</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Bola&#x000f1;os</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>Acoel Single&#x02010;Cell Atlas Reveals Expression Dynamics and Heterogeneity of Adult Pluripotent Stem Cells</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>14</volume>: <fpage>2612</fpage>.</mixed-citation></ref><ref id="eva70111-bib-0020"><mixed-citation publication-type="journal" id="eva70111-cit-0020">
<string-name>
<surname>Ivankovic</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Haneckova</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Thommen</surname>
</string-name>, et&#x000a0;al. <year>2019</year>. &#x0201c;<article-title>Model Systems for Regeneration: Planarians</article-title>.&#x0201d; <source>Development</source>
<volume>146</volume>, no. <issue>17</issue>: <elocation-id>dev167684</elocation-id>. <pub-id pub-id-type="doi">10.1242/dev.167684</pub-id>.<pub-id pub-id-type="pmid">31511248</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0021"><mixed-citation publication-type="journal" id="eva70111-cit-0021">
<string-name>
<surname>Jacqueline</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>P. A.</given-names>
<surname>Biro</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Beckmann</surname>
</string-name>, et&#x000a0;al. <year>2017</year>. &#x0201c;<article-title>Cancer: A Disease at the Crossroads of Trade&#x02010;Offs</article-title>.&#x0201d; <source>Evolutionary Applications</source>
<volume>10</volume>: <fpage>215</fpage>&#x02013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">28250806</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0022"><mixed-citation publication-type="journal" id="eva70111-cit-0022">
<string-name>
<surname>Jacques</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Baratchart</surname>
</string-name>, <string-name>
<given-names>K. J.</given-names>
<surname>Pienta</surname>
</string-name>, and <string-name>
<given-names>E. U.</given-names>
<surname>Hammarlund</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Origin and Evolution of Animal Multicellularity in the Light of Phylogenomics and Cancer Genetics</article-title>.&#x0201d; <source>Medical Oncology</source>
<volume>39</volume>: <fpage>160</fpage>.<pub-id pub-id-type="pmid">35972622</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0023"><mixed-citation publication-type="journal" id="eva70111-cit-0023">
<string-name>
<surname>Juliano</surname>, <given-names>C. E.</given-names>
</string-name>, <string-name>
<given-names>S. Z.</given-names>
<surname>Swartz</surname>
</string-name>, and <string-name>
<given-names>G. M.</given-names>
<surname>Wessel</surname>
</string-name>. <year>2010</year>. &#x0201c;<article-title>A Conserved Germline Multipotency Program</article-title>.&#x0201d; <source>Development</source>
<volume>137</volume>: <fpage>4113</fpage>&#x02013;<lpage>4126</lpage>.<pub-id pub-id-type="pmid">21098563</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0024"><mixed-citation publication-type="journal" id="eva70111-cit-0024">
<string-name>
<surname>Kauffman</surname>, <given-names>H. M.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Myron Kauffman</surname>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>McBride</surname>
</string-name>, et&#x000a0;al. <year>2002</year>. &#x0201c;<article-title>Transplant Tumor Registry: Donor Related Malignancies</article-title>.&#x0201d; <source>Transplantation</source>
<volume>74</volume>, no. <issue>3</issue>: <fpage>358</fpage>&#x02013;<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1097/00007890-200208150-00011</pub-id>.<pub-id pub-id-type="pmid">12177614</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0025"><mixed-citation publication-type="journal" id="eva70111-cit-0025">
<string-name>
<surname>Kicha</surname>, <given-names>A. A.</given-names>
</string-name>, <string-name>
<given-names>N. V.</given-names>
<surname>Ivanchina</surname>
</string-name>, <string-name>
<given-names>T. T. T.</given-names>
<surname>Huong</surname>
</string-name>, et&#x000a0;al. <year>2010</year>. &#x0201c;<article-title>Two New Asterosaponins, Archasterosides A and B, From the Vietnamese Starfish <italic toggle="yes">Archaster</italic>
<italic toggle="yes">t</italic>
<italic toggle="yes">ypicus</italic> and Their Anticancer Properties</article-title>.&#x0201d; <source>Bioorganic &#x00026; Medicinal Chemistry Letters</source>
<volume>20</volume>: <fpage>3826</fpage>&#x02013;<lpage>3830</lpage>.<pub-id pub-id-type="pmid">20493687</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0026"><mixed-citation publication-type="journal" id="eva70111-cit-0026">
<string-name>
<surname>Knudson</surname>, <given-names>A. G.</given-names>, <suffix>Jr.</suffix>
</string-name>
<year>1971</year>. &#x0201c;<article-title>Mutation and Cancer: Statistical Study of Retinoblastoma</article-title>.&#x0201d; <source>Proceedings of the National Academy of Sciences</source>
<volume>68</volume>: <fpage>820</fpage>&#x02013;<lpage>823</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0027"><mixed-citation publication-type="journal" id="eva70111-cit-0027">
<string-name>
<surname>Konishi</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Mohseni</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Tamaki</surname>
</string-name>, et&#x000a0;al. <year>2011</year>. &#x0201c;<article-title>Mutation of a Single Allele of the Cancer Susceptibility Gene <italic toggle="yes">BRCA1</italic> Leads to Genomic Instability in Human Breast Epithelial Cells</article-title>.&#x0201d; <source>Proceedings of the National Academy of Sciences</source>
<volume>108</volume>: <fpage>17773</fpage>&#x02013;<lpage>17778</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0028"><mixed-citation publication-type="journal" id="eva70111-cit-0028">
<string-name>
<surname>Lange</surname>, <given-names>C. S.</given-names>
</string-name>
<year>1966</year>. &#x0201c;<article-title>Observations on Some Tumours Found in Two Species of Planaria&#x02014;<italic toggle="yes">Dugesia etrusca</italic> and <italic toggle="yes">D. ilvana</italic>
</article-title>.&#x0201d; <source>Development</source>
<volume>15</volume>: <fpage>125</fpage>&#x02013;<lpage>130</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0029"><mixed-citation publication-type="journal" id="eva70111-cit-0029">
<string-name>
<surname>L&#x000f3;pez&#x02010;Nandam</surname>, <given-names>E. H.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Albright</surname>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Hanson</surname>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Sheets</surname>
</string-name>, and <string-name>
<given-names>S. R.</given-names>
<surname>Palumbi</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>Mutations in Coral Soma and Sperm Imply Lifelong Stem Cell Renewal and Cell Lineage Selection</article-title>.&#x0201d; <source>Proceedings of the Royal Society B: Biological Sciences</source>
<volume>290</volume>: <elocation-id>20221766</elocation-id>.</mixed-citation></ref><ref id="eva70111-bib-0030"><mixed-citation publication-type="journal" id="eva70111-cit-0030">
<string-name>
<surname>Macedo</surname>, <given-names>M. W. F. S.</given-names>
</string-name>, <string-name>
<given-names>N. B.</given-names>
<surname>Cunha</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Carneiro</surname>
</string-name>, et&#x000a0;al. <year>2021</year>. &#x0201c;<article-title>Marine Organisms as a Rich Source of Biologically Active Peptides</article-title>.&#x0201d; <source>Frontiers in Marine Science</source>
<volume>8</volume>: <elocation-id>667764</elocation-id>.</mixed-citation></ref><ref id="eva70111-bib-0031"><mixed-citation publication-type="journal" id="eva70111-cit-0031">
<string-name>
<surname>Magalh&#x000e3;es</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Andrade</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Sim&#x000f5;es</surname>
</string-name>, et&#x000a0;al. <year>2023</year>. &#x0201c;<article-title>Regeneration of Starfish Radial Nerve Cord Restores Animal Mobility and Unveils a New Coelomocyte Population</article-title>.&#x0201d; <source>Cell and Tissue Research</source>
<volume>394</volume>: <fpage>293</fpage>&#x02013;<lpage>308</lpage>.<pub-id pub-id-type="pmid">37606764</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0032"><mixed-citation publication-type="journal" id="eva70111-cit-0032">
<string-name>
<surname>Masters</surname>, <given-names>J. R.</given-names>
</string-name>
<year>2002</year>. &#x0201c;<article-title>HeLa Cells 50&#x02009;Years on: The Good, the Bad and the Ugly</article-title>.&#x0201d; <source>Nature Reviews Cancer</source>
<volume>2</volume>: <fpage>315</fpage>&#x02013;<lpage>319</lpage>.<pub-id pub-id-type="pmid">12001993</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0033"><mixed-citation publication-type="journal" id="eva70111-cit-0033">
<string-name>
<surname>Mihaylova</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Abnave</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Kao</surname>
</string-name>, et&#x000a0;al. <year>2018</year>. &#x0201c;<article-title>Conservation of Epigenetic Regulation by the MLL3/4 Tumour Suppressor in Planarian Pluripotent Stem Cells</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>9</volume>: <fpage>3633</fpage>.</mixed-citation></ref><ref id="eva70111-bib-0034"><mixed-citation publication-type="journal" id="eva70111-cit-0034">
<string-name>
<surname>Miram&#x000f3;n&#x02010;Pu&#x000e9;rtolas</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Pascual&#x02010;Carreras</surname>
</string-name>, and <string-name>
<given-names>P. R. H.</given-names>
<surname>Steinmetz</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>A Population of Vasa2 and Piwi1 Expressing Cells Generates Germ Cells and Neurons in a Sea Anemone</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>15</volume>: <fpage>8765</fpage>.</mixed-citation></ref><ref id="eva70111-bib-0035"><mixed-citation publication-type="journal" id="eva70111-cit-0035">
<string-name>
<surname>Muller</surname>, <given-names>H. J.</given-names>
</string-name>
<year>1964</year>. &#x0201c;<article-title>The Relation of Recombination to Mutational Advance</article-title>.&#x0201d; <source>Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</source>
<volume>1</volume>: <fpage>2</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0036"><mixed-citation publication-type="journal" id="eva70111-cit-0036">
<string-name>
<surname>Pearse</surname>, <given-names>A.&#x02010;M.</given-names>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Swift</surname>
</string-name>. <year>2006</year>. &#x0201c;<article-title>Transmission of Devil Facial&#x02010;Tumour Disease</article-title>.&#x0201d; <source>Nature</source>
<volume>439</volume>: <fpage>549</fpage>.<pub-id pub-id-type="pmid">16452970</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0037"><mixed-citation publication-type="journal" id="eva70111-cit-0037">
<string-name>
<surname>Queller</surname>, <given-names>D. C.</given-names>
</string-name>
<year>2000</year>. &#x0201c;<article-title>Relatedness and the Fraternal Major Transitions</article-title>.&#x0201d; <source>Philosophical Transactions of the Royal Society, B: Biological Sciences</source>
<volume>355</volume>: <fpage>1647</fpage>&#x02013;<lpage>1655</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0038"><mixed-citation publication-type="journal" id="eva70111-cit-0038">
<string-name>
<surname>Raikova</surname>, <given-names>E. V.</given-names>
</string-name>
<year>2008</year>. &#x0201c;<article-title>Cytomorphological Peculiarities of <italic toggle="yes">Polypodium hydriforme</italic> (Cnidaria)</article-title>.&#x0201d; <source>Journal of the Marine Biological Association of the United Kingdom</source>
<volume>88</volume>: <fpage>1695</fpage>&#x02013;<lpage>1702</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0039"><mixed-citation publication-type="journal" id="eva70111-cit-0039">
<string-name>
<surname>Ratajczak</surname>, <given-names>M. Z.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Bujko</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Mack</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kucia</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Ratajczak</surname>
</string-name>. <year>2018</year>. &#x0201c;<article-title>Cancer From the Perspective of Stem Cells and Misappropriated Tissue Regeneration Mechanisms</article-title>.&#x0201d; <source>Leukemia</source>
<volume>32</volume>: <fpage>2519</fpage>&#x02013;<lpage>2526</lpage>.<pub-id pub-id-type="pmid">30375490</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0040"><mixed-citation publication-type="journal" id="eva70111-cit-0040">
<string-name>
<surname>Shackleton</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Quintana</surname>
</string-name>, <string-name>
<given-names>E. R.</given-names>
<surname>Fearon</surname>
</string-name>, and <string-name>
<given-names>S. J.</given-names>
<surname>Morrison</surname>
</string-name>. <year>2009</year>. &#x0201c;<article-title>Heterogeneity in Cancer: Cancer Stem Cells Versus Clonal Evolution</article-title>.&#x0201d; <source>Cell</source>
<volume>138</volume>: <fpage>822</fpage>&#x02013;<lpage>829</lpage>.<pub-id pub-id-type="pmid">19737509</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0041"><mixed-citation publication-type="journal" id="eva70111-cit-0041">
<string-name>
<surname>Smilenov</surname>, <given-names>L. B.</given-names>
</string-name>
<year>2006</year>. &#x0201c;<article-title>Tumor Development: Haploinsufficiency and Local Network Assembly</article-title>.&#x0201d; <source>Cancer Letters</source>
<volume>240</volume>: <fpage>17</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">16223564</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0042"><mixed-citation publication-type="journal" id="eva70111-cit-0042">
<string-name>
<surname>Solana</surname>, <given-names>J.</given-names>
</string-name>
<year>2013</year>. &#x0201c;<article-title>Closing the Circle of Germline and Stem Cells: The Primordial Stem Cell Hypothesis</article-title>.&#x0201d; <source>EvoDevo</source>
<volume>4</volume>: <fpage>2</fpage>.<pub-id pub-id-type="pmid">23294912</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0043"><mixed-citation publication-type="journal" id="eva70111-cit-0043">
<string-name>
<surname>Soletti</surname>, <given-names>R. C.</given-names>
</string-name>, <string-name>
<given-names>G. P.</given-names>
<surname>de Faria</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Vernal</surname>
</string-name>, et&#x000a0;al. <year>2008</year>. &#x0201c;<article-title>Potentiation of Anticancer&#x02010;Drug Cytotoxicity by Sea Anemone Pore&#x02010;Forming Proteins in Human Glioblastoma Cells</article-title>.&#x0201d; <source>Anti&#x02010;Cancer Drugs</source>
<volume>19</volume>: <fpage>517</fpage>&#x02013;<lpage>525</lpage>.<pub-id pub-id-type="pmid">18418218</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0044"><mixed-citation publication-type="journal" id="eva70111-cit-0044">
<string-name>
<surname>Stocchino</surname>, <given-names>G. A.</given-names>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Manconi</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Overview of Life Cycles in Model Species of the Genus <italic toggle="yes">Dugesia</italic> (Platyhelminthes: Tricladida)</article-title>.&#x0201d; <source>Italian Journal of Zoology</source>
<volume>80</volume>: <fpage>319</fpage>&#x02013;<lpage>328</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0045"><mixed-citation publication-type="journal" id="eva70111-cit-0045">
<string-name>
<surname>Thomas</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Madsen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Giraudeau</surname>
</string-name>, et&#x000a0;al. <year>2019</year>. &#x0201c;<article-title>Transmissible Cancer and the Evolution of Sex</article-title>.&#x0201d; <source>PLoS Biology</source>
<volume>17</volume>: <elocation-id>e3000275</elocation-id>.<pub-id pub-id-type="pmid">31170137</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0046"><mixed-citation publication-type="journal" id="eva70111-cit-0046">
<string-name>
<surname>Tissot</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Meliani</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Boutry</surname>
</string-name>, et&#x000a0;al. <year>2024</year>. &#x0201c;<article-title>De Novo Evolution of Transmissible Tumours in Hydra</article-title>.&#x0201d; <source>Proceedings of the Royal Society B</source>
<volume>291</volume>: <elocation-id>20241636</elocation-id>.<pub-id pub-id-type="pmid">39288800</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0047"><mixed-citation publication-type="journal" id="eva70111-cit-0047">
<string-name>
<surname>Tolar</surname>, <given-names>J.</given-names>
</string-name>, and <string-name>
<given-names>J. P.</given-names>
<surname>Neglia</surname>
</string-name>. <year>2003</year>. &#x0201c;<article-title>Transplacental and Other Routes of Cancer Transmission Between Individuals</article-title>.&#x0201d; <source>Journal of Pediatric Hematology/Oncology</source>
<volume>25</volume>: <fpage>430</fpage>&#x02013;<lpage>434</lpage>.<pub-id pub-id-type="pmid">12794519</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0048"><mixed-citation publication-type="journal" id="eva70111-cit-0048">
<string-name>
<surname>Tomasetti</surname>, <given-names>C.</given-names>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Vogelstein</surname>
</string-name>. <year>2015</year>. &#x0201c;<article-title>Variation in Cancer Risk Among Tissues Can Be Explained by the Number of Stem Cell Divisions</article-title>.&#x0201d; <source>Science</source>
<volume>347</volume>: <fpage>78</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">25554788</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0049"><mixed-citation publication-type="journal" id="eva70111-cit-0049">
<string-name>
<surname>Tyner</surname>, <given-names>S. D.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Venkatachalam</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Choi</surname>
</string-name>, et&#x000a0;al. <year>2002</year>. &#x0201c;<article-title>p53 Mutant Mice That Display Early Ageing&#x02010;Associated Phenotypes</article-title>.&#x0201d; <source>Nature</source>
<volume>415</volume>: <fpage>45</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">11780111</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0050"><mixed-citation publication-type="journal" id="eva70111-cit-0050">
<string-name>
<surname>Ujvari</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<given-names>R. A.</given-names>
<surname>Gatenby</surname>
</string-name>, and <string-name>
<given-names>F.</given-names>
<surname>Thomas</surname>
</string-name>. <year>2016</year>. &#x0201c;<article-title>The Evolutionary Ecology of Transmissible Cancers</article-title>.&#x0201d; <source>Infection, Genetics and Evolution</source>
<volume>39</volume>: <fpage>293</fpage>&#x02013;<lpage>303</lpage>.</mixed-citation></ref><ref id="eva70111-bib-0051"><mixed-citation publication-type="journal" id="eva70111-cit-0051">
<string-name>
<surname>Vakhrusheva</surname>, <given-names>O. A.</given-names>
</string-name>, <string-name>
<given-names>E. A.</given-names>
<surname>Mnatsakanova</surname>
</string-name>, <string-name>
<given-names>Y. R.</given-names>
<surname>Galimov</surname>
</string-name>, et&#x000a0;al. <year>2020</year>. &#x0201c;<article-title>Genomic Signatures of Recombination in a Natural Population of the Bdelloid Rotifer <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Adineta vaga</italic>
</styled-content>
</article-title>.&#x0201d; <source>Nature Communications</source>
<volume>11</volume>: <fpage>6421</fpage>.</mixed-citation></ref><ref id="eva70111-bib-0052"><mixed-citation publication-type="journal" id="eva70111-cit-0052">
<string-name>
<surname>Van Roten</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>A. Z. A.</given-names>
<surname>Barakat</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Wouters</surname>
</string-name>, et&#x000a0;al. <year>2018</year>. &#x0201c;<article-title>A Carcinogenic Trigger to Study the Function of Tumor Suppressor Genes in <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Schmidtea mediterranea</italic>
</styled-content>
</article-title>.&#x0201d; <source>Disease Models &#x00026; Mechanisms</source>
<volume>11</volume>: <elocation-id>dmm032573</elocation-id>.<pub-id pub-id-type="pmid">29967069</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0053"><mixed-citation publication-type="journal" id="eva70111-cit-0053">
<string-name>
<surname>Voura</surname>, <given-names>E. B.</given-names>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>Montalvo</surname>
</string-name>, <string-name>
<given-names>K. T.</given-names>
<surname>dela Roca</surname>
</string-name>, et&#x000a0;al. <year>2017</year>. &#x0201c;<article-title>Planarians as Models of Cadmium&#x02010;Induced Neoplasia Provide Measurable Benchmarks for Mechanistic Studies</article-title>.&#x0201d; <source>Ecotoxicology and Environmental Safety</source>
<volume>142</volume>: <fpage>544</fpage>&#x02013;<lpage>554</lpage>.<pub-id pub-id-type="pmid">28482323</pub-id>
</mixed-citation></ref><ref id="eva70111-bib-0054"><mixed-citation publication-type="journal" id="eva70111-cit-0054">
<string-name>
<surname>Zayas</surname>, <given-names>R. M.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hern&#x000e1;ndez</surname>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Habermann</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>J. M.</given-names>
<surname>Stary</surname>
</string-name>, and <string-name>
<given-names>P. A.</given-names>
<surname>Newmark</surname>
</string-name>. <year>2005</year>. &#x0201c;<article-title>The Planarian <styled-content style="fixed-case" toggle="no">
<italic toggle="no">Schmidtea mediterranea</italic>
</styled-content> as a Model for Epigenetic Germ Cell Specification: Analysis of ESTs From the Hermaphroditic Strain</article-title>.&#x0201d; <source>Proceedings of the National Academy of Sciences</source>
<volume>102</volume>: <fpage>18491</fpage>&#x02013;<lpage>18496</lpage>.</mixed-citation></ref></ref-list></back></article>